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ABSTRACT
Context: Cortisol, the human glucocorticoid, plays a key role in the pathophysiology of
posttraumatic stress disorder (PTSD). It is known that individuals with chronic PTSD
suffer from low basal cortisol levels. Endogenic normalization of basal cortisol
concentration through exercise may have a therapeutic effect on treating PTSD
symptoms, yet little is known about the association between exercise-induced endogenic
increase of cortisol and PTSD symptom reduction. Objective: To identify whether
mindfulness-based stretching and deep breathing exercise (MBX) increases basal cortisol
levels, examine if MBX reduces PTSD symptom severity, and evaluate MBX as a
complementary intervention for PTSD. Design: Prospective, randomized, controlled.
Setting: University of New Mexico Hospital. Participants: 29 nurses with PTSD
symptoms, ages 45-53, with 28 female. Intervention: 8-week bi-weekly 60-minute MBX
vi

sessions. Main Outcome Measures: Serum cortisol and PTSD Checklist-Civilian
version (PCL-C) at weeks 0, 4, 8, 12, and 16. Results: Twenty-eight participants
completed the study procedures. In EX group, serum cortisol levels increased
significantly from 9.6±4.1 μg/dl at baseline to 14.6±5.7 μg/dl at week 8 (p=0.0039);
PTSD symptom severity decreased significantly from PCL-C scores of 43.1±11.2 at
baseline to 24±3.3 at week 8 (p=0.0002); and the effects were maintained at follow-up at
week 16 with cortisol concentration of 14.0±3.9 μg/dl (p= 0.5706) and PCL-C scores of
25.0±5.1 (p=0.8013). Conclusions: The results indicate a strong relationship between
changes in cortisol levels and changes in PTSD symptom severity. This study provides
preliminary evidence that programs aimed at reducing symptom severity in individuals
with chronic PTSD should consider a mind-body intervention. To our knowledge, this is
the first randomized controlled trial to assess the therapeutic benefits of MBX in
individuals with PTSD symptoms using both biomarkers and PCL-C scores measuring
the long-term effects of cortisol changes.
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CHAPTER I: INTRODUCTION
Background
Posttraumatic Stress Disorder (PTSD) is a chronic anxiety disorder (National
Center for PTSD 2011) that can occur in individuals who have been exposed to or have
witnessed a traumatic experience of an extreme nature (APA 2000). PTSD is
characterized by re-experiencing, hyperarousal, and avoidance, with persistent symptoms
of increased arousal in the autonomic nervous system (APA 2000) and somatic
disturbance (Rothschild 2000). In any given year, 7.7 million Americans over the age of
18 are diagnosed with PTSD (National Institute of Mental Health 2011), a debilitating
disorder that is often comorbid with other diseases (Libby 2012). Individuals with PTSD
often suffer substantial social and interpersonal problems which may significantly impair
many aspects of daily living (Mendlowicz and Stein 2000). Often PTSD patients
experience helplessness and a lost sense of self-control in their lives. Difficulties in
cognitive, emotional, and physiological processing during trauma have been identified as
one important predictor of the development of PTSD (Ozer, Best et al. 2003; Grodin,
Piwowarczyk et al. 2008). There is also increasing evidence that chronic PTSD sufferers
experience specific, unique neurobiological dysfunctions as a result of the uncontrollable
stress associated with the elevated levels of fear and anxiety (Southwick, Krystal et al.
1995) leading to abnormal function in the hypothalamic-pituitary-adrenal (HPA) axis and
the Sympathetic-adrenal-medullary (SAM) axis (Boscarino 2004).
In a normal stress response, the SAM pathway stimulates epinephrine (EPI) and
norepinephrine (NE) in the adrenal medulla evoking the “fight-or-flight” response, and
the HPA pathway triggers the release of cortisol from the adrenal cortex, together
1

functioning to maintain homeostasis in the human body (Heim and Nemeroff 2009).
Repeated stresses, however, evoke dissociation between HPA and SAM responses (de
Quervain 2006) and disrupt homeostasis. This dysfunction is manifested in abnormal
levels of catecholamines (Yehuda, Southwick et al. 1992) and cortisol (Mason, Giller et
al. 1986) in PTSD patients. Recent studies have posited that individuals with PTSD have
high catecholamine levels and low plasma and urinary cortisol levels (Yehuda 2003); that
low cortisol levels are correlated with PTSD symptom severity (Baker, West et al. 1999);
and that cortisol levels may change in relation with symptom modification (Yehuda,
Bierer et al. 2009) .
Substantial evidence has shown that mind‐body practices have a positive impact
on stress reduction, quality of life, and improvement of health outcomes among
individuals with PTSD.(Barnes 2008; National Institute of Mental Health 2011) In 2010,
39% of individuals with PTSD reported using complementary and alternative medicine
interventions, including mind-body exercises that incorporate various types of stretching
movements and postures with deep breathing (e.g., yoga, taichi, qigong, and meditation)
(Libby 2012).

Statement of the Problem
Current treatments for PTSD focus on reducing symptoms, improving functional
capacity and enhancing quality of life through the use of medication, and/or
psychotherapy. Other treatment options include Eye Movement Desensitization and
Reprocessing (EMDR), Cognitive Behavioral Therapy (CBT), Prolonged Exposure
Therapy, Cognitive Processing Therapy, and Stress Inoculation Training. While
2

psychotherapeutic and pharmacological interventions have some proven efficacy in the
management of PTSD symptoms (Grodin, Piwowarczyk et al. 2008; Lawrence, De Silva
et al. 2010), residual symptoms remain problematic. Current research has succeeded in
identifying treatments that lead to symptom reduction and also in quantifying the
neurobiological markers associated with PTSD symptom severity. For example, lasting
neurobiological changes in combat veterans with PTSD correlate with the manifestation
of specific symptoms including: increased 24-hour urinary norepinephrine positively
correlated with intrusive traumatic memories (Southwick, Bremner et al. 1999); and low
24-hour urinary cortisol levels correlated with a failure of normal memory consolidation
(Yehuda 2002c). Despite the advances made in the areas of pharmacology,
psychotherapy, and biology as they relate to PTSD, we still lack a complete
understanding of the anomalies of the autonomic nervous system in PTSD.
Recent studies have shown that low- to moderate-intensity mindfulness-based
exercise, such as tai chi or yoga, has positive effects on PTSD symptoms (Telles, Naveen
et al. 2007) including significant reductions in reported sleep disturbances, flashbacks
and anger outbursts (Brown and Gerbard 2005; Telles, Naveen et al. 2007; Grodin,
Piwowarczyk et al. 2008). In healthy individuals, exercise induces a transient increase in
cortisol (Brandenberger and Follenius 1975). However, the mechanisms of exerciseinduced neurophysiologic changes in PTSD patients are not yet clearly understood.
Furthermore, it is not yet clear if there is a link between exercise-induced PTSD symptom
reduction and a change in cortisol levels.

Purpose of the Study
3

The primary purpose of this study is to evaluate the relationship between exerciseinduced changes in plasma cortisol levels and changes in PTSD symptoms as they occur
during an 8-week program of mindfulness-based stretching and breathing exercises
compared to a wait-list control group.

Need for the Study
In any given year, 7.7 million Americans over the age of 18 are diagnosed with
posttraumatic stress disorder (PTSD) (National Institute of Mental Health 2011). In a
recent study of over 100,000 Operation Enduring Freedom and Operation Iraqi Freedom
(OEF/OIF) veterans seen at VA health care facilities between September 30, 2001 and
December 31, 2005, 25% received mental health diagnoses (Seal, Bertenthal et al. 2007).
PTSD represented 52% of these mental health diagnoses, making it the most commonly
diagnosed mental health issue among returning veterans (Seal, Bertenthal et al. 2007). As
greater numbers of combat veterans return home, PTSD has been an increasingly urgent
mental health issue as well as a source of social stress within military communities and
civilian communities with large active and retired military populations.
Furthermore, in a recent study, intensive care unit (ICU) nurses were also found
to be at high risk for developing PTSD as a result of repetitive exposure to extreme
stressors including high patient mortality and morbidity, daily exposure to traumatic
events, and the inability to adjust to extreme environments, with 24% of participating
nurses testing positive for PTSD symptoms (Mealer, Shelton et al. 2007). In the
workplace, persistent PTSD symptoms lead to reduced job satisfaction and productivity,
aversion to work (Gates and Gillespie 2008), and increased absenteeism (Laposa and
4

Alden 2003) and burnout (Acker 1993). The adverse health consequences of unmanaged
PTSD in nurses include headaches, gastrointestinal troubles, insomnia, eating disorders,
smoking, addiction, and anger displaced onto coworkers and patients (Gates and
Gillespie 2008). Considering the 17% vacancy rate for critical care nurses and a predicted
114,000 vacant critical care nursing positions in the United States by 2015, PTSD may be
a significant contributor to the increasing shortage of nurses and an exodus of the ICU
nurses (Mealer, Shelton et al. 2007).
Additionally, chronic activation of stress responses has negative effects on stressassociated immune dysregulation (Padgett and Glaser 2003) which, if left untreated, may
lead to a high rate of comorbidities of diseases (Boscarino 2004) such as digestive and
musculoskeletal disease, metabolic syndrome, cardiopulmonary diseases and depression.
Clearly, low cortisol level is related to increased morbidity during illness (Zaloga and
Marik 2001) and PTSD is one such case.

Hypotheses
1. Nurses who are positively screened for PTSD and participate in an 8-week program
of mindfulness-based stretching and breathing exercises would have greater changes
in cortisol levels compared to the wait-list control group.
2. Nurses who are positively screened for PTSD and participate in an 8-week program
of mindfulness-based stretching and breathing exercises would have greater changes
in PTSD symptom severity compared to the wait-list control group.
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3. There would be a positive association between exercise-induced reduction in PTSD
symptom severity and changes in cortisol levels as a result of participating in an 8week program of mindfulness-based stretching and breathing exercises.

Assumptions
1. The nurse PTSD patients in this sample are representative of nurse PTSD patients
throughout the United States.
2. Medical History Questionnaire, PAR-Q, and PCL-C were truthfully reported.
3. All instruments and cortisol analyses used in this study have high validity and
reliability.
4. The participants followed instructions regarding exercise, diet, and medications prior
to assessment.
Limitations
This study may be subject to the following limitations:
1. Testing effects: Because the PCL-C instrument will be repeatedly used at 5 time
points, we expect practice, familiarity or other forms of reactivity that could be taken
for treatment effects causing threat to internal validity. The PCL-C, however, has
high internal validity.
2. Generalizability: Since the participants are recruited from the UNM nurses only, the
results may not be applicable to the entire PTSD population in the United States.

Significance of the study

6

We currently lack a clear understanding of the effects of PTSD on the
physiological and neurobiological dysregulation of the autonomic nervous system.
Studies evaluating the effect of yoga, taichi, and qigong exercises have demonstrated
PTSD symptom reduction, including significant reductions in reported sleep
disturbances, flashbacks and anger outbursts (Brown and Gerbard 2005; Telles, Naveen
et al. 2007; Grodin, Piwowarczyk et al. 2008). In healthy individuals, exercise induces a
transient increase in cortisol (Brandenberger and Follenius 1975). It is not yet clear if
there is a link between exercise-induced PTSD symptom reduction and a change in
cortisol level. The contribution of the proposed research will be a better understanding of
the relationship between symptom reduction and changes in cortisol level as a result of an
exercise intervention. This contribution is significant because it will advance our
knowledge about the physiological regulation anomalies of the autonomic nervous system
associated with PTSD and will increase our understanding of how exercise improves
PTSD symptomology. For example, it is currently unclear whether low cortisol level is a
risk factor for PTSD or is low as a result of traumatic events. Making a connection
between changes in cortisol levels and PTSD symptoms that result from an exercise
intervention will advance our understanding of these complex dichotomies. It is also
expected that establishing this link will increase the recognition of exercise as an adjunct
PTSD treatment strategy, and improve patient motivation to try exercise as an adjunct to
other PTSD treatments. In addition, the research will be of significance because exercise
has the potential to positively address common comorbidities of PTSD such as
depression, cardiopulmonary diseases, and metabolic syndrome. As a complementary
therapy, exercise may improve current evidence-based psychotherapies and contribute to
7

more effective treatment of PTSD and greater improvement in quality of life at minimal
additional expense. This comparative study can elucidate the added value of an exercise
intervention by directly comparing changes in cortisol and symptom severity between the
treatment-as-usual group and the treatment-as-usual plus exercise group.

Definitions of Terms
The terms used in the study are defined as follows:
Adrenal medullae: Located at the center of the adrenal gland surrounded by the adrenal
cortex, consisting of cells that secrete epinephrine and norepinephrine. On the average,
approximately 80% of the secretion is epinephrine and 20% is norepinephrine (Guyton
1991).
Anxiety disorder: Any of a group of mental conditions that include panic disorder with
or without agoraphobia, agoraphobia without panic disorder, simple (specific) phobia,
social phobia, obsessive-compulsive disorder, posttraumatic stress disorder, acute stress
disorder, generalized anxiety disorder, anxiety caused by a general medical condition,
and substance-induced anxiety disorder (Venes 2009).
Autonomic nervous system: Part of the peripheral nervous system that controls visceral
functions affecting heart rate, digestion, respiration rate, salivation, perspiration, diameter
of the pupils, urination, and sexual arousal. It is divided into the parasympathetic nervous
system and sympathetic nervous system.
Catecholamines: Hormones released by the adrenal glands in response to stress,
including epinephrine, norepinephrine and dopamine.
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Cognitive Behavioral Therapy (CBT): A form of psychotherapy that aims to solve
problems concerning dysfunctional emotions, behaviors and cognitions through a goaloriented, systematic procedure in the present. CBT is reported to be somewhat superior to
antidepressants in the treatment of adult depression, and is equally effective as behavior
therapy in the treatment of adult depression and obsessive-compulsive disorder (Butler,
Chapman et al. 2006).
Cortisol: A glucocortical hormone of the adrenal cortex, usually referred to
pharmaceutically as hydrocortisone, and closely related to cortisone in its physiological
effects (Venes 2009). Cortisol is released in response to stress increasing blood sugar via
gluconeogenisis, suppressing the immune system, and metabolized in the liver with a
half-life of 60-90 minutes in the circulation.
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, a manual
published by the American Psychiatric Association (APA) that includes all currently
recognized mental health disorders.
Eye Movement Desensitization and Reprocessing (EMDR): A controversial method of
psychotherapy used for treating posttraumatic stress syndrome and anxiety disorders,
using a very short-term therapy for treating trauma victims that utilizes rhythmical
stimulation such as eye movements or hand taps (Shapiro 1998).
Epinephrine (EPI): A hormone, secreted by the adrenal glands during the fight-or-flight
response of the sympathetic nervous system, increases heart rate, constricts blood vessels,
and dilates air passages.
Hypothalamic-pituitary-adrenal (HPA) axis: A complex set of neuroendocrine
feedback systems among the hypothalamus, the pituitary gland, and the adrenal glands,
9

regulating reactions to stress and many bodily processes such as digestion, the immune
system, mood and emotions, and energy balance. HPA activity is shaped by a person's
response to the situation: a blunted hormonal response to stress may predispose a person
to develop PTSD (e.g., coftisol increases with subjective distress but is lower in persons
with PTSD) (Miller, Chen et al. 2007).
Norepinephrine (NE): A stress hormone and a neurotransmitter released from the
sympathetic neurons increasing the rate of cardiac contractions and blood flow to the
muscles, triggering the release of glucose from energy stores (Guyton 1991), and
affecting parts of the brain, such as the amygdala, where attention and responses are
controlled (Tanaka, Yoshida et al. 2000).
PAR-Q: The Physical Activity Readiness Questionnaire, a self-screening tool used prior
to starting an exercise program to determine the safety or possible risk of exercising for
an individual based upon their answers to specific health-related questions.
PCL-C: Posttraumatic Stress Disorder Checklist - Civilian version, a 17-item self-report
measure of the 17 DSM-IV symptoms of PTSD used for screening individuals for PTSD,
diagnosing PTSD, and monitoring symptom change during and after treatment.
Posttraumatic Stress Disorder (PTSD): A chronic anxiety disorder that can occur in
individuals who have been exposed to or have witnessed a traumatic experience of an
extreme nature (APA 2000). PTSD is characterized by re-experiencing, hyperarousal, and
avoidance, with persistent symptoms of increased arousal in the autonomic nervous
system (APA 2000) and somatic disturbance (Rothschild 2000).
Qigong: A mind–body exercise originating from traditional Chinese medicine combining
meditation, controlled breathing and gentle, physical movements designed to direct
10

mental attention to specific areas of the body (Posadzki, Parekh et al. 2010) aiming to
improve health by reducing stress, anxiety, and depression as well as to improve physical
activity and balance (Stenlund, Ahlgren et al. 2009).
Sympathetic-adrenal-medullary (SAM) axis: The SAM pathway, often equated with
the sympathetic nervous system (SNS) and under the control of the central nervous
system (CNS), elicits the desired fight or flight mode by sending a signal to the adrenal
medulla via the spinal cord, triggering the secretion of epinephrine and norepinephrine
and preparing the nervous system to respond to a threat (Cannon 1914).

List of Abbreviations
CBT = Cognitive Behavioral Therapy
EMDR = Eye Movement Desensitization and Reprocessing
EPI = Epinephrine
HPA axis = Hypothalamic-pituitary-adrenal axis
ICU = Intensive care unit
NE = Norepinephrine
OEF = Operation Enduring Freedom
OEI = Operation Iraqi Freedom
PAR-Q = Physical Activity Readiness Questionnaire
PCL-C = Posttraumatic Stress Disorder Check List - Civilian version
PTSD = Posttraumatic Stress Disorder
SAM axis = Sympathetic-adrenal-medullary axis
VA = Veterans Affairs
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CHAPTER II: LITERATURE REVIEW
This chapter presents a review manuscript that was submitted to and accepted
by the Journal of Investigative Medicine under the condition of appropriate revision. The
references cited in this review are provided at the end of the manuscript. A review of
literature is also included in this chapter.
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A Review: Mind-body Practices for Posttraumatic Stress Disorder
ABSTRACT
Background: Mind-body practices are increasingly used to provide stress reduction for
posttraumatic stress disorder (PTSD). Methods: This is a literature review using
PubMed, PsycINFO, and PILOTS to identify the exercise components of mind-body
practices such as yoga, taichi, qigong, mindfulness-based stress reduction, meditation,
and deep breathing as interventions for PTSD. Results: The literature search identified
92 articles. We reviewed only original, full text articles that met the inclusion criteria.
Most of the studies have small sample size, but findings from the 12 publications
reviewed here suggest that mind-body practices are associated with positive impacts on
PTSD symptoms. Mind-body exercise incorporates numerous therapeutic effects on
stress responses, including dramatic reductions in anxiety, depression, and anger, and
increases in pain-tolerance, self-esteem, energy levels, ability to relax, and ability to cope
with stressful situations. In general, mind-body exercise was found to be a viable
intervention to improve the constellation of PTSD symptoms such as intrusive memories,
avoidance, and increased emotional arousal. Conclusions: Mind-body exercise is
increasingly employed in the treatment of PTSD and is associated with positive impacts
on stress-induced illnesses such as depression and PTSD. Knowledge about the diverse
modalities of mind-body practices may provide clinicians and patients with the
opportunity to explore an individualized and effective treatment plan enhanced by mindbody practice as part of ongoing self-care.
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Introduction
Posttraumatic stress disorder (PTSD) is an anxiety disorder that results from
exposure to a traumatic event.(APA, 1987) In any given year, 7.7 million Americans over
the age of 18 are diagnosed with PTSD,(National Institute of Mental Health, 2011) a
debilitating disorder that is often comorbid with other diseases.(Libby, 2012) Individuals
with PTSD suffer substantial social and interpersonal problems, as well as impaired
quality of life stemming from the long-term presence of the intrusive, avoidant and
hyperaroused symptoms that characterize the disease. Although pharmacological and
cognitive therapy interventions have some proven efficacy in the treatment of
PTSD,(Grodin, Piwowarczyk, Fulker, Bazazi, & Saper, 2008) residual symptoms remain
problematic.
Substantial evidence has shown that mind‐body practices have a positive impact
on quality of life, stress reduction, and improvement of health outcomes among
individuals with PTSD.(Barnes, 2008; National Institute of Mental Health, 2011) In
2010, 39 percent of individuals with PTSD reported using complementary and alternative
medicine (CAM) interventions, including mind-body practices that incorporate various
types of stretching movements and postures with deep breathing (e.g., yoga, taichi,
qigong, and meditation).(Libby, 2012) However, the neural and biological mechanisms
that underlie a mind-body approach to managing PTSD symptoms are not well
delineated. The purpose of this article is to review the evidence that supports the
effectiveness of mindfulness-based strategies.

Materials and Methods
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Study Inclusion Criteria
We searched for peer-reviewed original journal articles in English on the effects
of a mindfulness-based approach to treat PTSD. We included demographics, PTSD
symptoms (i.e., intrusive thought, flashback, avoidance, numbness, hyperarousal), and
heart rate variability (HRV) as variables.

Search Strategy
Our literature searches of PubMed/MEDLINE, EBSCO/PsycINFO, and the
Published International Literature on Traumatic Stress (PILOTS) database took place on
March 5th, 2012. We used combinations of the search terms “mindfulness” or “mindbody”, and “exercise” or “yoga” or “taichi” or “qigong” or “meditation” and
“posttraumatic stress disorder” or “PTSD”.

Inclusion Criteria
We initially screened abstracts published in English that included human
participants with PTSD. Those abstracts included randomized control trials, comparative
studies, and observational studies that evaluated the efficacy of mind-body interventions
on PTSD symptom changes. For articles that passed the initial screening, we retrieved the
full articles to assess eligibility.

Methodological Quality Grade
For critical appraisal of the literature reviewed for the study, we used a
methodological quality assessment of ten questions adapted from Young and Solomon
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(Table 1).(Young & Solomon, 2009) To assign a nominal quality grade for the selected
studies, we used a three category grading system of A, B, and C which we adapted from
the Evidence-based Practice Centers (EPCs) of the Agency for Healthcare Research and
Quality (AHRQ).(EPC Evidence Reports) Category A articles have valid outcomes, the
least bias, adequate methods to assess the intervention, clear inclusion and exclusion
criteria, and clear descriptions of the study population, setting, interventions and
comparison groups. Category B articles have some bias but not a sufficient amount to
invalidate the outcomes, as well as some of the deficiencies in the criteria for category A
and/or missing data. Category C articles have significant biases that may invalidate the
outcomes, serious errors in study design and analysis, and/or a large amount of missing
data.

Results
We screened 92 English language abstracts and selected for review a total of 12
articles that met the inclusion criteria (Figure 1). Four randomized controlled trials
(RCT), 7 non-randomized studies (NRS), and 1 observational noncontrolled study (OBS)
with a total of 824 participants were selected for review (Table 2). Seventy-six
publications did not meet the inclusion criteria: 27 articles were unrelated to the study
subject, 9 were from book chapters, 7 were dissertations, 22 were editorials or reviews,
and 12 journals were unavailable. Twenty-six articles overlapped across more than two
search engines. Two articles were available only in PubMed. Of the 12 studies reviewed,
two examined the effects of yoga; three the effects of meditation, or meditation and
relaxation; one the effects of taichi and qigong; two the efficacy of mindfulness-based
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stress reduction (MBSR); one the effects of relaxation, or relaxation plus deep breathing,
or relaxation plus deep breathing and thermal biofeedback; and three studies examined
the effects of mind-body skills (a combination of various mindfulness-based approaches).
Ten studies reported significant positive effects of mind-body practices on reduction of
PTSD symptoms via regulation of the sympathetic and/or parasympathetic nervous
systems (Table 3). Seven studies did not have a control group. Of the 12 reviewed
articles, 4 received an A quality score, 5 received a B score, and 3 received a C score
(Table 2). Studies that received a C score had a significant amount of missing data.

Studies on PTSD Symptom Severity
Although there were several common elements in the reviewed studies, such as
mindfulness, exercise, meditation, and deep breathing, the outcome parameter for
assessing “changes in PTSD symptom severity” varied. The common measures of
symptom severity were performed using self-rated instruments such as the PTSD
CheckList (PCL), the Harvard Trauma Questionnaire (HTQ), the UCLA PTSD Index for
DSM-IV (UPID), the PTSD Reaction Index (PTSD-RI) and the Child PTSD Symptom
Scale (CPSS). Of the 12 reviewed studies (Table 2), two studies showed no statistically
significant outcomes,(Telles, Singh, Joshi, & Balkrishna, 2010; Watson, Tuorila, Vickers,
Gearhart, & Mendez, 1997) and 10 studies showed a significant decrease of PTSD
symptom severity as a result of participation in a mind-body intervention.(Catani et al.,
2009; Descilo et al., 2010; J S Gordon, Staples, Blyta, & Bytyqi, 2004; J. S. Gordon,
Staples, Blyta, Bytyqi, & Wilson, 2008; Grodin, et al., 2008; Kearney, McDermott,
Malte, Martinez, & Simpson, 2012; Kimbrough, Magyari, Langenberg, Chesney, &
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Berman, 2010; Rosenthal, Grosswald, Ross, & Rosenthal, 2011; Staples, 2011; Waelde et
al., 2008) In the 10 studies that incorporated follow-up testing ranging from 3 months to
15 months following intervention, positive results were maintained.(Catani, et al., 2009;
Descilo, et al., 2010; J S Gordon, et al., 2004; J. S. Gordon, et al., 2008; Grodin, et al.,
2008; Kearney, et al., 2012; Kimbrough, et al., 2010; Rosenthal, et al., 2011; Staples,
2011; Waelde, et al., 2008) Six studies reported decreases in specific PTSD symptom
clusters including hyperarousal, avoidance, and numbing. (Catani, et al., 2009; J. S.
Gordon, et al., 2008; Kearney, et al., 2012; Staples, 2011; Waelde, et al., 2008; Watson,
et al., 1997)
The four RCTs share common mindfulness-based components of relaxation,
meditation, and deep breathing. Watson and colleagues(Watson, et al., 1997) compared
relaxation, relaxation plus deep breathing, and relaxation plus deep breathing and thermal
biofeedback. The authors reported pre-test PTSD Index scores of 95.4, 95.0; 98.1, and
post-test PTSD Index scores of 97.8; 90.5, 89.4 for relaxation, relaxation plus deep
breathing, and relaxation plus deep breathing and thermal biofeedback, respectively, but
they found no significant difference between groups (Table 3). These results suggest that
deep breathing and thermal biofeedback may not have additional therapeutic effects for
PTSD. Conversely, Catani and colleagues(Catani, et al., 2009) found that a short-term
meditation-relaxation intervention significantly reduced PTSD symptoms. The
investigators randomized 31 children into meditation-relaxation (MED-RELAX) or
Narrative Exposure Therapy (KIDNET) interventions one month after the Tsunami in the
North-Eastern region of Sri Lanka. After 6-sessions conducted over a 2-week period,
participation in the MED-RELAX program was associated with a significant reduction in
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PTSD symptoms (UPID scores of 36.58 and 12.59, pre- and posttest respectively,
Cohen’s d = 1.83) (Table 3). More importantly, these results were as effective as the
conventional KIDNET PTSD therapy (UPID scores of 37.94 and 12.41, pre- and posttest
respectively, Cohen’s d = 1.76). Furthermore, the 6-month follow-up UPID scores were
9.75 (80% recovery rate) and 12.3 (70% recovery rate) for MED-RELAX and KIDNET
respectively, demonstrating the long-term effectiveness of MED-RELAX.
Rosenthal and collegues(Rosenthal, et al., 2011) also reported that transcendental
meditation has a significant positive impact on alleviating PTSD symptoms among
veterans returning from Operation Enduring Freedom or Operation Iraqi Freedom with
combat-related PTSD (Figure 2A). All subjects (n = 5) showed significant mean
reductions in the Clinician Administered PTSD Scale (CAPS) and the PTSD ChecklistMilitary Version with decreases of 31.4 (p = 0.02) and 24.00 (p < 0.02) points,
respectively. Similarly, the RCT conducted in 2008 by Gordon and colleagues(J. S.
Gordon, et al., 2008) showed decreases in PTSD symptoms in postwar Kosovar
adolescents. The authors randomized 82 high school students into a 12-session mindbody skills program or a wait-list control group. HTQ scores improved significantly (2.5
and 2.0, pre- and posttest, respectively, p < 0.001). These findings were consistent with
the results from their previous pilot study in 2004 (Table 2). Furthermore, they reported
that all 3 PTSD symptom clusters were significantly reduced after MBSR intervention:
re-experiencing (p = 0.001), avoidance and numbing (p < 0.001), and hyperarousal (p =
0.001) (Figure 2B).
Kearney and colleagues reported that 40% of veterans (n = 92) who practiced
mindfulness-based stress reduction (MBSR) showed clinically significant reduction in
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PTSD symptom severity at two months, the symptom improvement was maintained at the
6-month follow-up (Figure 3A). On the other hand, Staple and colleagues reported that
individuals with higher baseline scores of symptom severity showed greater improvement
in response to the mind-body skills intervention, but the gains did not entirely persist at
follow-up (Figure 3B).

Studies on Vagal Activity
HRV is the cyclic variation in the duration between successive heartbeats. It is
used as an index to measure changes in the autonomic nervous system,(Song et al., 2011)
and is a reliable marker of vagal (parasympathetic) activity of the heart, as well as stress
vulnerability.(Porges, 1995) In general, decreased HRV reflects increased sympathetic
regulation and stress,(Dishman et al., 2000) and is associated with increased PTSD
symptom severity.(Cohen et al., 1998) One study that examined the relationship between
mind-body practice and HRV during the stress response following a natural disaster
showed no improvement in Heart Rate Variability among individuals with
anxiety.(Telles, et al., 2010) After a month of natural disasters in north India, Telles et al.
(2012)(Telles, et al., 2010) assessed 1,089 disaster victims using the Screening
Questionnaire for Disaster Mental Health (SQD) to obtain scores for PTSD and
depression. Twenty-two participants were randomized into yoga therapy or wait-list
control groups. Researchers collected HRV data using frequency domain analysis for
very low frequency (VLF) band (0.0-0.04 Hz), low frequency (LF) band (0.5-0.15 Hz),
high frequency (HF) band (0.15-0.50 Hz), as well as the LF/HF ratio (Table 3). They also
recorded time domain HRV analysis using pNN50, the percentage of successive normal
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cardiac interbeat intervals greater than 50 msec.(Telles, et al., 2010) No significant
changes were found in the HRV between the groups. Of note, after seven days of yoga
training, the yoga group showed a significant decrease in sadness (p < 0.05), and the nonyoga group showed increased anxiety (p < 0.05).

Discussion
This review demonstrates that mind-body practices are currently being used to
treat PTSD and that multiple components of such practices may provide therapeutic
effects for rapid and sustained relief of PTSD symptoms.(Catani, et al., 2009; Descilo, et
al., 2010; J S Gordon, et al., 2004; J. S. Gordon, et al., 2008; Grodin, et al., 2008; Staples,
2011; Telles, et al., 2010; Watson, et al., 1997) Mind-body practices appear to be safe for
participants with PTSD, and the observed positive impacts in clinical outcome measures
were generally sustained at follow-up. Ten out of twelve studies showed a positive
impact of a mind-body approach and demonstrated significant improvements in PTSD
symptom severity. The broad range of geographic and demographic elements in the
selected studies suggests that mind-body interventions are beneficial across a wide
variety of populations.

Lasting Effects of Short-term Mind-body Practices
Considering that early intervention is critical in ameliorating the development of
PTSD,(Descilo, et al., 2010) and that PTSD symptoms are strongly correlated with the
degrees of distress immediately following the trauma,(Descilo, et al., 2010) short-term
mind-body interventions ranging from 2 to 8 weeks may provide a potent
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nonpharmacological treatment for individuals with PTSD. Of particular interest is the
finding that mediation-relaxation was as effective as Narrative Exposure Therapy for
reducing PTSD sympomatology in children.(Catani, et al., 2009) This suggests that in
the immediate aftermath of a traumatic event, mind-body exercise may reduce intrusive
thoughts of trauma and promote extinction of fear, even in the absence of conventional
therapy.(Catani, et al., 2009) Furthermore, despite the short duration of the interventions,
the effects of PTSD symptom reduction appear to be long lasting.(Catani, et al., 2009; J.
S. Gordon, et al., 2008; Staples, 2011)

Time, Age and Gender Factors for PTSD Treatment
Staples and colleagues(Staples, 2011) demonstrated that following a mind-body
intervention, there was a highly significant effect of time, suggesting that early
intervention is critical in treating PTSD. They also found that individuals with higher
baseline scores showed greater improvements in PTSD, but that higher baseline PTSD
symptoms were not correlated with age. Gender had significant effects regarding
avoidance symptoms, with male children showing greater improvement in scores from
baseline to follow-up than females. Additionally, Waelde and his colleagues(Waelde, et
al., 2008) suggested that the total time spent in meditation practice is positively
associated with greater improvement in PTSD symptom severity. In summary, it is likely
that mind-body interventions for children are highly effective in older children at the
early stage of development of PTSD, and that longer practice may have a greater impact
in PTSD symptom reduction.
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Parasympathetic Regulation
Although PTSD symptom severity is associated with increased heart rate
variability,(Cohen, et al., 1998) the one study examining HRV that we reviewed did not
find a significant effect of yoga on HRV. In the reviewed study,(Telles, et al., 2010) the
absence of change in HRV may be due to the nature of the exercise protocol and the
particular breathing techniques applied. Cohen and colleagues(Cohen, et al., 1998) stated
that HRV is closely related to the breath rate,(Cohen, et al., 1998) and that fast breathing
stimulates the sympathetic nervous system while slow breathing activates vagal activity,
leading to reduced psycho-physiologic arousal. The combination of fast and slow
breathing used in the study may have failed to influence the HRV, resulting in no
significant change, suggesting that slow breathing practice alone may increase
parasympathetic function and HRV for individuals with symptomatic PTSD. Further
investigation regarding the effect of mind-body exercise and deep breathing may
elucidate a relationship between the frequency and depth of breath and vagal activity.

Clinical Implications of Mind-body Interventions
Evidence presented in this review supports mind-body exercise as an efficacious
adjunct therapy for the treatment of PTSD. Mind-body practices may contribute to
decreasing PTSD symptoms by offering participants opportunities to reduce stress levels,
improve mood, reduce the intensity of PTSD arousal symptoms, and observe what they
experience from a more relaxed state with less fear and more equanimity in an
environment of greater social-support via group-activity.(Staples, 2011) Figure 4 depicts
a schematic representation of how patients with PTSD might be apportioned to mind30

body exercises as a component of their therapy, as well as the expected benefits of such
an approach.
Individuals with PTSD increasingly use mind-body practices as an alternative or
adjunct to conventional care for PTSD. Clinicians should discuss mind-body
interventions with their patients and educate them about the benefits of mind-body
practice to maximize the diversity of treatment options.(Libby, 2012) Knowledge of
modalities of mind-body interventions, and of providers in the community who can direct
mind-body intervention, may provide patients with the opportunity to explore
individualized self-care therapies. Further studies are warranted to assess the
comprehensive effects of the mind-body practices on treating comorbid diseases and
improving quality of life.

Limitations
The research methodologies included in this review were heterogeneous, and the
quality of the studies varied widely. Due to differences in design, intervention methods,
and study duration, as well as the presence or absence of control groups, we were unable
to conduct a true meta-analysis. The study by Gordin and colleagues(Grodin, et al., 2008)
was the only qualitative research included in this review. Despite the lack of quantitative
outcomes, we included the study because of the long study duration (>1 yr) and the
significant findings described therein. Most of the studies we reviewed for potential
inclusion in the study did not have a control group, and two of the reviewed articles had a
large amount of missing data.(Staples, 2011) Attrition was problematic in one study, with
31 percent of the study participants dropping out after baseline data were
31

collected.(Descilo, et al., 2010) Additionally, the mean ages of study participants ranged
from 11.95 to 51 years in the reviewed studies, with predominantly male subjects or a
mixture of both genders. Future studies need to include younger or older populations to
examine whether the demonstrated efficacy may be generalized, particularly to female
subjects.

Conclusions
Future studies need to replicate these findings in other cultural settings with
varied populations, preferably with larger samples, an untreated control group, and
additional outcome measures such as biomarkers (i.e., cortisol, adrenocorticotropic
hormones, epinephrine, and norepinephrine). Elucidation of the relationships between
changes in psychological symptoms and changes in the biomarkers will advance our
understanding of the nonpharmacologic psycho-biological mechanism(s) of mind-body
practices for clinical application. Further research will enable us to validate the role of
mind-body practices in preventing and treating PTSD so that these strategies, together
with other lifestyle modifications and psychotherapies, become a part of the standard
treatment regimen for PTSD in the future.
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FIGURE 2. (A) Mean scores of CAPS and PCL-M decreased after 8-week meditation.
Adapted from Rosenthal et al (2011). † p = 0.02. ‡ p < 0.02. (B) Percent of participants
with PTSD symptom clusters measured by Harvard Trauma Questionnaire (HTQ) after a
12-session mind-body program at baseline, post-treatment at weeks 4, and follow-up at
weeks 12. Adapted from Gordon et al (2008). * p = 0.001. ** p < 0.001.
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CHAPTER III
A RESEARCH MANUSCRIPT
This chapter presents a complete manuscript that describes this study in
proposed format, which includes an abstract, introduction, procedures, results,
conclusion, and reference sections. This manuscript will be submitted to the Journal of
Clinical Endocrinology & Metabolism. The formatting and style guidelines of the journal
were used in the manuscript.
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Mindfulness-based Stretching and Deep Breathing Exercises Normalize Serum
Cortisol Levels and Reverse Symptoms of PTSD: A Prospective RandomizedControlled Trial

Sang Hwan Kim, Suzanne M. Schneider, Len Kravitz, Christine Mermier, Clifford
Qualls, and Mark R. Burge
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ABSTRACT
Context: Cortisol, the human glucocorticoid, plays a key role in the pathophysiology of
posttraumatic stress disorder (PTSD). It is known that individuals with chronic PTSD
suffer from low basal cortisol levels. Endogenic normalization of basal cortisol
concentration through exercise may have a therapeutic effect on treating PTSD
symptoms, yet little is known about the association between exercise-induced endogenic
increase of cortisol and PTSD symptom reduction. Objective: To identify whether
mindfulness-based stretching and deep breathing exercise (MBX) increases basal cortisol
levels, examine if MBX reduces PTSD symptom severity, and evaluate MBX as a
complementary intervention for PTSD. Design: Prospective, randomized, controlled.
Setting: University of New Mexico Hospital. Participants: 29 nurses with PTSD
symptoms, ages 45-53, with 28 female. Intervention: 8-week bi-weekly 60-minute MBX
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sessions. Main Outcome Measures: Serum cortisol and PTSD Checklist-Civilian
version (PCL-C) at weeks 0, 4, 8, 12, and 16. Results: Twenty-eight participants
completed the study procedures. In EX group, serum cortisol levels increased
significantly from 9.6±4.1 μg/dl at baseline to 14.6±5.7 μg/dl at week 8 (p=0.0039);
PTSD symptom severity decreased significantly from PCL-C scores of 43.1±11.2 at
baseline to 24±3.3 at week 8 (p=0.0002); and the effects were maintained at follow-up at
week 16 with cortisol concentration of 14.0±3.9 μg/dl (p= 0.5706) and PCL-C scores of
25.0±5.1 (p=0.8013). Conclusions: The results indicate a strong relationship between
changes in cortisol levels and changes in PTSD symptom severity. This study provides
preliminary evidence that programs aimed at reducing symptom severity in individuals
with chronic PTSD should consider a mind-body intervention. To our knowledge, this is
the first randomized controlled trial to assess the therapeutic benefits of MBX in
individuals with PTSD symptoms using both biomarkers and PCL-C scores measuring
the long-term effects of cortisol changes.

Abbreviations: PTSD, posttraumatic stress disorder; PCL-C, PTSD Checklist-Civilian
version; MBX, mindfulness-based stretching and deep breathing exercise; HPA axis,
hypothalamic-pituitary-adrenal axis; CRH, corticotrophin-releasing hormone; ACTH,
adrenocorticotropic hormone; DHEAS, dehydroepiandrosterone-sulfate; HRV, heart rate
variability; MDD, major depressive disorder.
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Introduction
Posttraumatic stress disorder (PTSD) is a type of anxiety disorder that can result from
exposure to a traumatic event (APA, 1987). In any given year, 7.7 million Americans
over the age of 18 are diagnosed with PTSD (National Institute of Mental Health, 2011).
A recent study of intensive care unit (ICU) nurses found them to be at high risk for
developing PTSD as a result of repetitive exposure to extreme stressors including high
patient mortality and morbidity, daily exposure to traumatic events, and the inability to
adjust to extreme environments, with 24% of participating nurses testing positive for
PTSD symptoms (Mealer, Shelton, Berg, Rothbaum, & Moss, 2007). In the workplace,
persistent PTSD symptoms lead to reduced job satisfaction and productivity, aversion to
work (Gates & Gillespie, 2008), and increased absenteeism (Laposa & Alden, 2003),
compassion fatigue (Potter et al., 2010), and burnout (Acker, 1993). Considering the 17%
vacancy rate for critical care nurses and a predicted 114,000 vacant critical care nursing
positions in the United States by 2015, PTSD may be a significant contributor to the
increasing shortage of critical care nurses (Mealer, et al., 2007).
PTSD is a debilitating disorder that is often comorbid with other diseases (Libby,
2012) such as hypertension, diabetes, metabolic syndrome, and depression. Individuals
with PTSD also suffer substantial social and interpersonal problems and impaired quality
of life stemming from the long-term presence of intrusive, avoidant and hyperarousal
symptoms. Although pharmacological and cognitive therapy interventions have proven
efficacy in the treatment of PTSD (Grodin, Piwowarczyk, Fulker, Bazazi, & Saper,
2008), residual symptoms remain problematic. Substantial evidence has shown that
mind‐body practices have a positive impact on quality of life, reduce stress, and improve
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health outcomes among individuals with PTSD (Barnes, 2008; National Institute of
Mental Health, 2011). In 2010, 39% of individuals with PTSD reported using
complementary and alternative medicine (CAM) interventions, including mind-body
practices that incorporate various types of stretching movements and postures with deep
breathing (i.e., yoga, tai chi, and qigong) (Libby, 2012). In our study, we sought to
explore the underlying neuroendocrinologic mechanism of these types of observed
improvements in quality of life measures by examining the changes in three key stressrelated biomarkers (i.e., cortisol, ACTH, DHEAS) associated with the hypothalamicpituitary-adrenal (HPA) axis, a key area of interest in individuals with stress-related
disorders.
In healthy individuals, the HPA axis functions to adapt the body to new acute
stressors through a cascade of hormonal responses of secretion of corticotrophinreleasing hormone (CRH) in the hypothalamus, release of adrenocorticotropic hormone
(ACTH) in the anterior pituitary gland, and secretion of glucocorticoids in the adrenal
cortex (Robert M. Sapolsky, Romero, & Munck, 2000). However, chronic elevation of
glucocorticoids, often coupled with genetic factors, personal traumatic history, and
unhealthy lifestyle, have deleterious effects on the body (McEwen, 2002) leading to
dysregulation of the HPA axis. Dysfunction of the HPA axis (Yehuda & Golier, 2009),
characterized by abnormally high levels of CRH and low levels of cortisol (Fig. 1) is one
of the distinct neuroendocrine profiles that differentiates PTSD from other mental
illnesses (Yehuda, 2002b).
Cortisol, the human glucocorticoid, plays a key role in the pathophysiology of
PTSD. In healthy individuals, an increase in basal cortisol levels is associated with
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improvement in declarative memory and performance accompanied by normalized
glucose metabolism in the limbic system (i.e., hippocampus, amygdala, and prefrontal
cortex) (Twamley, Hami, & Stein, 2004). Patients with chronic PTSD are known to have
decreased basal cortisol levels (Boscarino, 1996), though not all studies agree with this
finding (Lemieux & Coe, 1995; Mason et al., 2002; Pitman & Orr, 1990), and a greater
sensitivity of cortisol negative feedback inhibition in the HPA axis compared to those
without PTSD (Yehuda, 2002b). In persons with chronic PTSD, basal cortisol level
increases are associated with symptom improvement (Aerni et al., 2004). A recent study
has shown that the administration of intravenous hydrocortisone improves working
memory in combat veterans with PTSD compared with a control group without PTSD
(Jenkins, Langlais, Delis, & Cohen, 1998).
We know that exercise is associated with a transient increase in plasma cortisol
(Brandenberger & Follenius, 1975) and improved cognitive function (Twamley, et al.,
2004) in healthy individuals. A study by Telles and colleagues (2007) showed that lowto moderate intensity mindfulness-based interventions, such as tai chi and yoga, have
positive effects on PTSD symptoms (Telles, Naveen, & Dash, 2007) raising the question
of whether there is an accompanying change in basal cortisol levels associated with the
improvement in PTSD symptoms. There is considerable research to support the
neuroprotective benefits of exercise for people with chronic stress. Moderate-intensity
exercise has been shown to have neurobiological effects on chronic stress-related
symptoms including improved regulation of the serotonergic system (Weicker & Struder,
2001), counteraction of degradation of the hippocampus caused by chronic stress,
reduction of neurobiological sensitivity to stress, and normalization of catecholamine
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levels (Chytrova, Ying, & Gomez-Pinilla, 2008; Tsatsoulis & Fountoulakis, 2006). In this
study, we examined the potential for low- to moderate intensity exercise-induced
endogenic normalization of basal cortisol coupled with a mindfulness component to
enhance emotional regulation and cognitive function, and reduce symptom severity in
individuals with PTSD.
Mindfulness is a quality of consciousness that is associated with control of
attention and awareness (R. M. Sapolsky, 2004). Mindfulness-based exercise promotes a
direct awareness of bodily movement, sensations, and surroundings, thus often inducing
positive psychological and behavioral responses. Studies have shown that mindfulnessbased exercise interventions, such as yoga, tai chi, and qigong, lead to symptom
reduction in patients with PTSD (Brown & Gerbard, 2005; Grodin, et al., 2008; Telles, et
al., 2007). For example, Vietnam veterans who practiced yoga for six weeks showed a
significant reduction in the mean scores of the Center for Epidemiologic Studies
Depression Scale (CES-D) and the 17-item Hamilton Rating Scale for Depression
(HRSD-17) as well as a reduction in reported sleep disturbances, flashbacks, and anger
outbursts (Brown & Gerbard, 2005).
What is less clear is the impact of exercise on the endocrinologic anomalies
associated with PTSD such as reduced cortisol and abnormally high levels of CRH. It has
been established that individuals with chronic PTSD suffer from low basal cortisol levels
(Boscarino, 1996); that low basal cortisol levels are correlated with PTSD symptom
severity (Baker et al., 1999); and that basal cortisol levels may change in relation with
symptom modification (Yehuda, Bierer, et al., 2009). In healthy people, we know that
immediately following exercise, cortisol levels are elevated (Brandenberger & Follenius,
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1975); and that after exercise at a lower work rate (55 % VO2max) for a longer duration
(up to 3 hours), plasma cortisol concentrations rise higher than those observed at a higher
work rate (80 % VO2max) for a shorter duration (within 1 hour) (Robson, Blannin, Walsh,
Castell, & Gleeson, 1999). However, there is little evidence of a long-term impact of
exercise on basal cortisol levels because the majority of research in this area has focused
on transient changes in cortisol concentrations. To fill that gap, this study tracked
changes in basal serum cortisol over a 16-week period, with 8 weeks of exercise and an
8-week follow up.
In addition to low plasma and urinary cortisol levels (Yehuda, 2003), PTSD
patients also have abnormally high secretion of CRH (Baker, et al., 1999; Bremner et al.,
1997; Sautter et al., 2003) but a low level of ACTH (Smith et al., 1989). CRH is secreted
in the hypothalamus and inhibited by the hippocampus (Herman et al., 1989; Jacobson &
Sapolsky, 1991); and abnormally high secretion of CRH is associated with PTSD
symptom severity (Yehuda, 2002b). Studies have shown that chronically elevated CRH
in the cerebrospinal fluid (CSF) is associated with a blunted ACTH response to CRH
leading to hyposecretion of ACTH in the pituitary gland (Bremner et al., 2003; Heim,
Newport, Bonsall, Miller, & Nemeroff, 2001; Smith, et al., 1989), which may decrease
the secretion of cortisol in the adrenal cortex (hypocortisolaemia) (Smith, et al., 1989).
On the other hand, dehydroepiandrosterone sulfate (DHEAS), a glucocorticoid antagonist
secreted in the adrenal cortex, is known to have a counteracting effect against excess
glucocorticoid-induced neurotoxicity in the brain and prevent excitotoxic cell death in the
hippocampus (Kimonides, Khatibi, Svendsen, Sofroniew, & Herbert, 1998). Endogenic
production of DHEAS is reduced by age, stress, or illnesses (Goodyer et al., 1996).
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Rasmusson and colleagues reported that DHEAS may play a role in resilience to stress,
protecting against the development of PTSD symptom clusters such as avoidance and
hyperarousal and that there is a positive correlation between serum DHEAS/cortisol ratio
and human performance under extreme stress (2004). Interestingly, Jones and Moller
reported that increase in DHEAS levels may indirectly inhibit the hyperactivity of
amygdala leading to reduction of PTSD symptom severity (Jones & Moller, 2011).
Johnson and colleagues found that exercise significantly elevates dehydroepiandrosterone
levels (1997). Also of note, DHEAS, antiglucocorticoid secreted episodically and
synchronously with glucocorticoids in response to ACTH concentrations (Rosenfeld et
al., 1971), protects the brain from stressors (Kimonides, et al., 1998). Increase in DHEAS
and ACTH may be associated with improvement of the brain function and PTSD
symptom reduction. We therefore chose to measure plasma ACTH and serum DHEAS to
examine whether there would be a relationship between exercise-induced change in
PTSD symptom severity and changes in the levels of serum DHEAS and plasma ACTH
as a result of exercise.
The primary question this research attempted to answer was whether the resting
Ante Meridiem (AM) serum cortisol levels increase in individuals with PTSD as a result
of exercise, and how a potential exercise-induced increase in basal cortisol relates to
PTSD symptom reduction. Endogenic normalization of cortisol concentration through
exercise may have a therapeutic effect on treating PTSD symptoms. Therefore, we sought
to explore whether mindfulness-based stretching and deep breathing exercise (MBX)
increases cortisol levels, examine if MBX reduces PTSD symptom severity, and evaluate
MBX as a complementary intervention for PTSD. We hypothesized that an exercise51

induced reduction in PTSD symptoms would be positively associated with elevation in
basal cortisol levels as a result of participating in an 8-week MBX program. To test this
hypothesis, we conducted a prospective randomized controlled trial in nurses with PTSD
symptoms to determine the effect of MBX-induced changes in cortisol levels on PTSD
symptom severity. We also examined the ratios of cortisol/DHEAS and cortisol/ACTH to
determine whether MBX would be associated with a significant change in either of these
ratios.

Materials and Methods
Human Subjects and Study Protocols
Nurse volunteers were recruited from the University of New Mexico Hospital
through advertisement and gave their written consent prior to enrolling in the study.
Initial screening of volunteers was conducted using the PTSD Checklist Civilian version
(PCL-C), a 17-item self-reported instrument with good test–retest reliability and internal
consistency (Blanchard, Jones-Alexander, Buckley, & Forneris, 1996). Inclusion criteria
were a total PCL-C score of at least 28, with a score of 3 or higher on one or more
individual items. Exclusion criteria included an inability to participate in the exercise
program, a positive answer to any of the seven screening questions on the Physical
Activity Readiness Questionnaire (PAR-Q), or current use of systemic glucocorticoid.
Demographics and medical history were obtained at baseline. Changes in PTSD
symptoms and fasting serum cortisol were assessed at an individually standardized time
(around 8:00 AM) at weeks 0, 4, 8, 12, and 16. This decision was based on the reports
from previous studies on lower morning cortisol levels in those with PTSD than in
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healthy individuals (Boscarino, 1996) and negative relationship between morning cortisol
and PTSD symptomology (Kellner, Baker, & Yehuda, 1997). We also obtained fasting
plasma ACTH and DHEAS at pre- and postintervention at the same time. Participants
were instructed to refrain from the following for 72 hours prior to the blood draw and the
compliance was verified by participants’ self-reporting: drinking alcohol, taking any
nonprescription drugs unless absolutely necessary, and engaging in vigorous exercise. On
three occasions, participants requested rescheduling for phlebotomy because they had
consumed alcohol or exercised within 72 hours prior to the scheduled blood draw.

Mind-body Intervention
A series of 16 standardized, bi-weekly 60-minute MBX classes were led by a
trained instructor and conducted in a conference room of the Clinical and Translational
Science Center (CTSC) of the University of New Mexico. Each class included stretching
and balancing movements (see Index for exercise demonstration) combined with deep
breathing. Throughout the exercise sessions, the participants were instructed to pay
attention to the flow of each movement at the present moment with a focus on conscious
regulation of inhalation, retention, and exhalation of the breath. Particular emphasis was
given on creating inner environment of positive attitude and feeling the self as it is
throughout the class. Over the course of the 8 weeks, the intensity of the exercise
increased but the sequence of the movements was substantially the same. Participants
were asked to practice the exercise protocol at home if they chose to and record the
duration of exercise time each week in a home exercise log.
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Study Design and Randomization
We conducted a 3-arm prospective randomized controlled study. Twenty-nine
adults participated in the study. Of 29, 22 participants who were positively screened for
PTSD symptoms were randomized by coin-flip into an 8-week course of mind-body
exercise group (EX) (n=11) or a control group (CON) (n=11). Seven participants who
were negatively screened for PTSD were assigned to a healthy group (BASE) to establish
baseline data for cortisol, ACTH and DHEAS in this population. After being assigned to
BASE group, these participants did not complete any additional PCL-C evaluations
because they are not symptomatic of PTSD. Study protocol and procedures were
approved by the Human Research Review Committee (HRRC), the institutional review
board of the University of New Mexico. We obtained oral informed consent from
participants before telephone eligibility screening. Those who were eligible provided
written informed consent prior to study enrollment.

Cortisol, ACTH and DHEAS
Serum cortisol was measured using a blood draw at baseline, weeks 4, and 8 for
all groups. For EX group, serum cortisol was also measured at 12-week and 16-week
follow-ups. Serum DHEAS and plasma ACTH were measured using a blood drawn at
baseline and week 8 for all groups with an additional follow-up measurement for EX
group at week 16. This series of cortisol, DHEAS and ACTH data were used to track
changes in biomarker levels over the course of the study.

PCL-C Scores
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The PCL-C, a 17-item self-reported instrument, measures the 17 Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) symptoms of PTSD including intrusive
recollection, flashbacks, anhedonia, estrangement from others, foreshortened future, and
impaired concentration (7). In a test with a sample of individuals with a variety of
traumatic experiences, the PCL instrument showed a good test–retest reliability and
internal consistency (Blanchard, et al., 1996; F. Weathers, Litz, Herman, Huska, &
Keane, 1993). It is used for a variety of purposes including screening and diagnosing
individuals for PTSD as well as monitoring symptom change during and after
intervention. Participants self-report the symptom severity by rating each item on a scale
ranging from 1 (not at all) to 5 (extremely) (7). Possible scores range from 17 to 85.
Inclusion criteria were set at a total score of 28, with at least one individual item scored 3
or higher. Our primary interest was in tracking the change in symptom severity in
individuals with high self-reported levels of stress. Participants were considered
symptomatic of PTSD if they met the inclusion criteria but were not clinically diagnosed
with PTSD.

Statistical Analysis
The study was originally designed to be a repeated-measures cross-over design.
However, after reviewing the outcomes there appeared to be an order effect, and thus the
data had to be treated as just two groups. Data analyses were conducted on the basis of
intent-to-treat. We compared the changes of outcome variables at pre- and
postintervention using a two-tailed t-test. We then examined each outcome over time,
measuring changes in symptom severity of PCL-C scores and cortisol levels to identify
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the effects of participation in the 8-week exercise program on each variable using
repeated measures of Analysis of Variance (ANOVA). We also examined potential
effects of confounders and interaction with intervention by covariates including age,
gender, ethnicity, education, marital status, smoking status, body mass index (BMI), and
duration of nursing experience. Patient characteristic variables are summarized in Table
1. Statistical analyses were conducted using SPSS and STATA.

Results
Study participants
Of 63 screened subjects, 29 met the inclusion criteria. Of 29, 22 were enrolled in
the PTSD symptomatic groups and randomized into either EX or CON group and 7 were
assigned to non-PTSD symptomatic BASE group. Of 22 in the PTSD symptomatic
group, 21 completed the study procedures. Seven participants in the BASE group
completed the study. The one subject in the control group who did not complete the study
withdrew due to family-related personal matters. One participant (9%) attended 12
classes out of 16 total classes, 6 (55%) attended 13 classes, 3 (27%) attended 14 classes,
and 1 (9%) attended 16 classes. Participants in the PTSD symptomatic groups were aged
46.3±9.0 years and had mean body mass index (BMI) of 27.2±6.2 kg/m² whereas
participants in non-PTSD symptomatic group were aged 44.7±16.2 years and had mean
BMI of 25.5±3.2 kg/m². One participant declined to answer regarding the duration of
nursing experience.

Effect of exercise on overall PTSD symptom severity
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As shown in Fig. 3, 8 weeks of MBX significantly reduced self-reported PTSD
symptom severity in the exercise group as measured by PCL-C (from mean PCL-C score
of 43.1±11.2 to 24.3±3.3, p=0.0002). Fig. 4 graphically represents both the reductions of
PCL-C scores in each subjects and the overall trends toward lower PCL-C scores from
baseline (red line) through week 8 (green line) as shown by the movement of data points
toward the center of the graph. The mean postintervention PCL-C score of 24.3 was
below the study inclusion criteria of a score of 28. Conversely, the control group mean
PCL-C scores showed no significant change in 8 weeks (from 42.6±12.7 to 41.0±16.3,
p=0.6572) (Table 2). A comparison of the mean decrease for the exercise and control
groups showed a significant difference in the outcomes for those who had the
intervention and those who did not (p=0.009). The mean decrease in the exercise group
PCL-C score was 18.82±10.6 and the mean decrease in the control group PCL-C score
was 1.60±11.0 (Table 3). There was a significant group-time interaction (p = 0.02).

Effect of exercise on subtypes of PTSD symptom severity
PTSD is characterized by three subtypes of symptoms: reexperiencing, avoidance
and hyperarousal. Each cluster can be evaluated separately on a subscale using a distinct
subset of questions from the PCL-C questionnaire. As shown in Fig. 5, the exercise group
showed a significant reduction in each of the three PCL-C subscales. Mean
reexperiencing scores decreased from 2.5±0.7 to 1.4±0.3 (p=0.0003) (Fig.5a). Mean
avoidance scores fell from 2.5±0.8 to 1.4±0.3 (p=0.0007) (Fig.5b). Mean hyperarousal
scores decreased from 2.7±0.9 to 1.5±0.4 (p=0.0005) (Fig.5c). The control group PCL-C
subscale changes were not significant, changing from 2.6±1.1 to 2.4±1.1 (p=0.5593) for
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the reexperiencing cluster, from 2.5±0.6 to 2.5±0.8 (p=0.8754) for the avoidance cluster,
and from 2.8±0.8 to 2.7±1.1 (p=0.9315) for the hyperarousal cluster.
At the 16-week follow-up (Table 4), the improvement in PCL-C scores was
maintained. The mean PCL-C score at 16 weeks was 25.0±5.1 compared to the 8-week
mean score of 24.3±3.3 (p=0.8013).
Effect of exercise on serum cortisol
Serum cortisol concentrations in the exercise group rose from 9.6±4.1 μg/dl to
14.7±5.7 μg/dl (p=0.0039) after 8 weeks of MBX (Fig. 6A and 7). The control group
showed no significant change in serum cortisol concentration (12.9±6.9 μg/dl to 12.9±4.9
μg/dl, p=0.3566) at pre- and postintervention (Table 2). Comparison of cortisol levels
between EX and BASE groups revealed that there was a significant difference at
preintervention (9.6 μg/dl, 13.9 μg/dl, EX and BASE respectively, p = 0.0350) but there
was no difference at postintervention (14.6 μg/dl, 14.8 μg/dl, EX and BASE respectively,
p = 0.4893). At the 16-week follow-up, the changes in the exercise group were
maintained. The mean serum cortisol at 16 weeks was 14.0±3.9 μg/dl compared to the
postintervention measure of 14.7±5.7 μg/dl (p=0.5706). A comparison of the mean
increase in cortisol level for both groups showed a significant difference, with the
exercise group experiencing a mean increase of 5.06±4.5 μg/dl and the control
experiencing a mean increase of 0.82±4.2 μg/dl (p=0.0188, Table 3).

Effect of exercise on other biomarkers
We also examined the effect of exercise on ACTH and DHEAS at
postintervention. In the exercise group, there were no significant changes in levels of
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ACTH (19.8 pg/ml preintervention and 22.2 pg/ml postintervention, p=0.1306) or
DHEAS (85.6 μg/dl preintervention and 94.8 μg/dl postintervention,
p=0.1897). However, the ACTH levels of the exercise group were significantly higher
postintervention than in the control group (F (1, 19) = 6.78, p = 0.0108), whereas the
DHEAS levels of the exercise group showed no significant difference from the control
group postintervention (F (1, 19) = 0.02, p = 0.8768). In addition, there were significant
changes in the exercise group’s cortisol/ACTH ratio (increased from 0.65 to 0.87,
p=0.0231) and cortisol/DHEAS ratio (increased from 0.15 to 0.20, p=0.0126) (Fig. 8).

Correlation of PTSD symptoms with hormone responses
There was a significant positive correlation between the participation in the MBX
intervention and the PCL-C scores in the EX group: r = 0.67, p = 0.001 (Fig. 6A), but
there was no significant correlation between the change in cortisol in response to exercise
and total PCL-C scores at postintervention: r = 0.18, p = 0.467 (Fig. 6B). When
controlling for participation in exercise, 0.38 unit increase in cortisol is associated with a
one point decrease in the PCL-C score (PCL-C 3 = - 0.38 cortisol 3 – 11.6 exercise +
44.6073, R2 = 0.27) (Fig. 9)

Discussion
This is the first randomized controlled trial to examine the therapeutic benefits of
mindfulness-based stretching and breathing exercises in individuals with PTSD using
both biomarkers and self-reported symptom severity scores. Participation in an 8-week
MBX program yielded a 44% reduction in PCL-C scores and a 34% increase in serum
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cortisol concentration. The effects were maintained at week 16. There were no significant
differences in ages, ethnicity, education, marital status, smoking status, and nursing
experience of the exercise group compared to the control group.
In a comparison of cortisol levels between the EX and BASE groups, cortisol
levels in the EX group were significantly lower at preintervention (p = 0.0350) but there
was no significant difference at postintervention (p = 0.3639), indicating that
normalization of cortisol levels may have occurred in the exercise group as a result of the
intervention. Our data demonstrate that 8-week MBX intervention which significantly
increased serum cortisol levels at week 8 also resulted in a significant reduction of PTSD
symptom severity.
Considering that abnormally high secretion of CRH is associated with PTSD
symptom severity (Yehuda, 2002b), the MBX-induced increase of cortisol levels, via
negative feedback inhibition, may have reduced CRH secretion in the hypothalamus
leading to decrease in PTSD symptom severity. This finding is consistent with previous
studies demonstrating that administration of cortisol after trauma reduces the likelihood
of developing PTSD (Yehuda, Bierer, et al., 2009) and decreases the retrieval of fear
memories (Schelling et al., 2006). However, it is not clear whether an exercise-induced
endogenous increase of cortisol would be different compared to exogenously
administered cortisol on the changes of PTSD symptoms.
We also analyzed the three subtypes of PTSD symptoms: reexperiencing,
avoidance and hyperarousal. The exercise group showed a 44% reduction in the mean
scores of reexperiencing and avoidance subscales, and a 42% decrease in mean
hyperarousal subscale scores whereas there were no significant differences in the
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subscale scores in the control group. Our data show that an MBX intervention has
comparable effects on all three symptom clusters resulting in improvement of both
clinically and neurobiologically opposing symptom characteristics: undermodulated
emotional dysregulation (reexperiencing and hyperarousal subtypes) and overmodulated
emotional dysregulation (avoidance and numbness) (Lanius et al., 2010). Lanius and
colleagues (2010) categorized undermodulated symptoms as being mediated by failure of
prefrontal inhibition of limbic regions and overmodulated symptoms as being overly
controlled by midline prefrontal inhibition of the limbic regions (Lanius, et al., 2010).
Our findings have significant implications for the development of comprehensive
intervention for PTSD which addresses the normalization of both overmodulation and
undermodulation of emotional dysregulation. Together, these data support our hypothesis
that exercise-induced reduction in PTSD symptoms is positively associated with changes
in cortisol levels as a result of participating in an 8-week MBX program.
Furthermore, compliance among participants in the intervention was high: all 11
participants completed the intervention attending at least 75% of the 16 classes.
Anecdotally, during their 8-week participation in the intervention, many participants
voluntarily reported to the instructor that they experienced improved sleep patterns, felt
more resistant to stress, had improved energy levels, felt better able to control their
emotions under stress, and resumed engaging in pleasurable hobbies which they had
discontinued due to high levels of stress. At the end of the intervention, more than half of
the participants expressed a desire to continue attending classes. Given the hurdles to
compliance with current PTSD treatment options, the high levels of voluntary compliance
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with the MBX intervention suggest that it may be an attractive self-care option with a
high level of patient adherence.
A unique component of MBX interventions versus typical low- to moderateintensity exercise is the inclusion of slow and deep breathing in synchronization with the
exercise movements. Slow breathing is known to have a balancing effect on the
autonomic nervous system via enhanced parasympathetic activation. Jerath and
colleagues (2006) reported that slow and deep breathing stimulates stretch-induced
inhibitory signals and hyperpolarizes currents propagated in the cells leading to
synchronization of neural elements in the heart, lungs, limbic system and cortex (Jerath,
Edry, Barnes, & Jerath, 2006). Cohen and colleagues (Cohen et al., 1998) stated that slow
breathing enhances heart rate variability (HRV) and vagal activity, leading to reduced
psycho-physiologic arousal. Although we did not examine HRV in the study, HRV can
be used as an index to measure changes in the autonomic nervous system (Song et al.,
2011) and is a reliable marker of vagal (parasympathetic) activity of the heart, as well as
stress vulnerability(Porges, 1995). In general, increased HRV reflects decreased
sympathetic regulation and stress (Dishman et al., 2000), and is associated with reduced
PTSD symptom severity (Cohen, et al., 1998).
The analysis of ACTH and DHEAS at postintervention reveals that there was no
significant increase in the concentrations of ACTH and DHEAS in the exercise group.
However, mean ACTH levels in the EX group were significantly higher than in the CON
group at 8 weeks.
Additionally, the changes in the ratios of cortisol/ACTH and cortisol/DHEAS in the EX
were significant. Both ratios were significantly higher at postintervention compared to
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preintervention, indicating that the rate of increase in cortisol was greater than the rate of
increase in ACTH or DHEAS. We speculate that this result may be an indicator of MBXinduced up-regulation of the adrenal cortex via enhanced adrenocortical sensitivity to
ACTH leading to increased cortisol release. Further study is needed to understand the
exact mechanism at work. Rasmusson and colleagues (2004) reported that an increase in
DHEA is negatively correlated with PTSD symptom severity and DHEA to cortisol ratio
is inversely related with negative mood symptoms in premenopausal women with PTSD
(Rasmusson, et al., 2004). Interestingly, as seen in Figure 10, postintervention DHEAS
levels were greater compared with preintervention DHEAS levels although statistically
insignificant. The increase in DHEAS levels may have been associated with reduction of
PTSD symptom via the mechanism of indirect inhibition of the hyperactivity of amygdala
(Jones & Moller, 2011). However, our data showed no significant association between
PTSD symptom severity and DHEAS levels, possibly due to the small sample size of our
study and the reliance on biomarker measurement taken at one point in time.
Measurement of changes in cortisol concentrations may be important in
understanding the pathogenesis of PTSD, clinical assessment of physiological responses
to stress, and treatment of PTSD (Matousek, Dobkin, & Pruessner, 2010). Recent studies
have shown that lifetime PTSD is associated with significantly lower cortisol levels
(Yehuda, Halligan, & Bierer, 2002d) and the differences in cortisol predict or correlate
with response to treatment for PTSD symptoms (Yehuda, Bierer, et al., 2009). Recent
studies reported that individuals with PTSD and lower urinary cortisol levels are
significantly less responsive to psychotherapy treatment (Yehuda, Bierer, et al., 2009),
and the levels of cortisol predict gene expression in the HPA axis as well as the brain and
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immune cell function (Yehuda, Cai, et al., 2009). Yehuda and colleagues (2009) reported
that FK506-binding protein (FKBP506), a modulator of glucocorticoid receptor (GR)
sensitivity, is associated with PTSD symptom severity and cortisol levels. The authors
conducted genetic studies measuring plasma cortisol using radioimmunoassay and
identified a role of FKBP506 in PTSD: FKBP506 expression is reduced in PTSD and is
predicted by cortisol levels, particularly in those with childhood trauma and current
PTSD (Yehuda, Cai, et al., 2009). The authors suggested that lower cortisol levels may
contribute to the progression to chronic, treatment-resistant PTSD via attenuation of
peripheral catabolism of cortisol and suppression of HPA axis responsiveness (Yehuda,
Bierer, et al., 2009).
As the participants in our study were primarily female, we ad hoc considered
estradiol to be an important factor in PTSD symptom manifestation. Unfortunately, we
did not obtain estradiol samples due to limited study resources. This will be of interest in
our future studies as recent research has elucidated the role of estradiol in modulating the
HPA axis and suggested a sex-specific genetic association of pituitary adenylate cyclaseactivating polypeptide (PACAP), which is a regulator of the cellular stress response,
impacting fear physiology, PTSD diagnosis and symptoms in females (Kageyama &
Suda, 2009; Ressler et al., 2011).
This study is limited by a small number of participants who were predominantly
female nurses with PTSD symptoms; thus there may be problems with generalizability of
the outcomes to males and individuals with combat-related trauma. Because the study
participants were not clinically diagnosed with PTSD, there may be also issues with
generalizability to patients with a diagnosed PTSD. However, given the small number of
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PTSD-related studies conducted exclusively on civilian female populations, our findings
may shed light on characteristics specific to a population that has received little attention
to date. It should be noted that our findings are limited by the absence of inclusion of the
participants’ menstrual cycle data.
In screening for study eligibility and PTSD symptom severity of the participants,
we used PCL-C, a 17-item self-reported instrument, without diagnosis of PTSD.
However, the PCL instrument has a good test–retest reliability and internal consistency
(Blanchard, et al., 1996) with good psychometric properties (F. W. Weathers, Keane, &
Davidson, 2001). The inclusion criteria were set sufficiently high to ensure that all
participants in the EX and CON groups had levels of self-reported stress that were high
enough to negatively impact their quality of life on a daily basis and to be PTSD
symptomatic.
Additionally, since the time windows of phlebotomy were between 7:45 and 9:00
AM, there may be inaccuracy of assessing the morning surge of cortisol secretion in the
8:00 AM. Nonetheless, most of the participants’ phlebotomy times were internally
consistent throughout the study. Participants were instructed to fast for 10-hours prior to
phlebotomy and the resting cortisol levels were measured at least 72 hours after exercise
to rule out the transient effects of exercise on cortisol levels.
In summary, in this study of human endocrine and exercise physiology we have
demonstrated that after participation in an 8-week mind-body exercise intervention,
participants experienced substantial increases in serum cortisol concentration with
concurrent reduced PTSD symptom severity. Considering that early intervention is
critical in ameliorating the development of PTSD (Descilo et al., 2010) and that PTSD
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symptoms are strongly correlated with the degrees of distress immediately following the
trauma (Descilo, et al., 2010), short-term mind-body interventions such as an 8-week
mind-body intervention may provide a potent nonpharmacological treatment for
individuals with PTSD. Long-term studies that examine the neuroendocrine responses of
cortisol and CRH, using blood oxygen level-dependent (BOLD) brain imaging or an
immunoassay such as YK130 CRF Elisa Kit (Gentaur, Paris, France), are warranted.
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TABLE 1. Baseline demographic and clinical characteristics.*
Characteristics
Age (years)
Sex (female)
Smoking status
Ever smoked
Never smoked
Body mass index
Ethnic origin
African
American Indian
Hispanic or Latino
White (Not Hispanic or Latino)
Education
College degree
Graduate degree
Marital status
Ever married
Never married
Nursing experience
Less than 5 yrs
6-10 yrs
11-15 yrs
More than 15 yrs
Baseline outcomes
PCL-C score
Cortisol (μg/dl)
ACTH (pg/ml)
DHEAS ((μg/dl)
†

Exercise group
(n = 11)
47.6 (7.7)
10 (91)

Control group
(n = 11)
45.0 (10.0)
11 (100)

Base group
(n = 7)
44.6 (16.2)
7 (100)

5 (45)
6 (55)
26.9 (5.1)

4 (36)
7 (64)
27.4 (7.3)

1 (14)
6 (86)
25.5 (3.2)

1 (9)

1 (14)

4 (36)
6 (55)

1 (9)
3 (27)
7 (64)

4 (57)
2 (29)

9 (82)
2 (18)

9 (82)
2 (18)

4 (57)
3 (43)

8 (73)
3 (27)

8 (73)
3 (27)

3 (27)

2 (18)
2 (18)

8 (73)

7 (64)

4 (57)
3 (43)
**
2 (33)
1 (17)
1 (17)
2 (33)

43.1 (11.2)
9.6 (4.1)
19.8 (10.8)
85.6 (33.7)

42.4 (12.1)
13.2 (6.6)
12.4 (4.6)
91.1 (66.2)

21.8 (3.4)
13.9 (5.8)
14.8 (5.4)
90.6 (66.0)

Data are means (SD) or numbers (%).
One participant declined to answer about the length of nursing experience.

††
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TABLE 2. Summary results of PCL-C scores and Cortisol at Pre- and Postintervention.

PCL-C total
PCL-C subscales
Reexperiencing
Avoidance
Hyperarousal
Cortisol

a

Exercise group (n=11)
Baseline
Wk 8
p-value
43.1 (11.2)
24.3 (3.3)
0.0002***

Control group (n=11)
Baseline
Wk 8
p-value
42.6 (12.7)
41.0 (16.3)
0.6572

2.5 (0.7)
2.5 (0.8)
2.7 (0.9)
9.6 (4.1)

2.6 (1.1)
2.5 (0.6)
2.8 (0.8)
12.9 (6.9)

1.4 (0.3)
1.4 (0.3)
1.5 (0.4)
14.6 (5.7)

0.0003***
0.0008***
0.0005***
0.0039**

2.4 (1.1)
2.5 (0.8)
2.7 (1.1)
13.8 (5.7)

0.5593
0.8754
0.9315
0.5487

a

Data are means (SD). SD, standard deviation. Unit of cortisol = µm/dl. p-values are for two-sided ttest.
p-values are for two-sided t-test. Starred values are significant at the ***0.1 percent and **1 percent levels.

TABLE 3. Comparison of the change in mean PCL-C scores and cortisol levels for Exercise and
a
Control Groups.
p-value
Exercise Group
Control Group
PCL-C mean decrease
Cortisol mean increase

18.82 (10.6)
5.06 (4.5)

1.60 (11.0)
0.82 (4.2)

0.0009***
0.0188*

a

Data are means (SD). SD, standard deviation. Unit of cortisol = µm/dl. p-values are for two-sided ttest. Starred values are significant at the ***0.1 percent and *5 percent levels.

TABLE 4. Summary results of follow-up PCL-C scores and Cortisol values for exercise group.

a

EXERCISE GROUP
PCL-C total
PCL-C subscales
Reexperiencing
Avoidance
Hyperarousal
Cortisol
a

Wk 8
24.3 (3.3)

Wk 16
25.0 (5.1)

p-value
0.8013

1.4 (0.3)
1.4 (0.3)
1.5 (0.4)
14.6 (5.7)

1.5 (0.4)
1.3 (0.3)
1.7 (0.5)
14.0 (3.9)

0.6783
0.4269
0.7517
0.5706

Data are means (SD). Unit of cortisol = µm/dl. Values are in mean (SD). p-values are for two-sided t-

test.
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FIG. 1. Schematic illustration of HPA axis regulation. CRH in the hypothalamus is released to the
anterior pituitary gland stimulating ACTH secretion, which stimulates the adrenal cortex, triggering
glucocorticoids (human cortisol) release. Cortisol regulates CRH and ACTH secretion via a
negative feedback inhibition loop. In individuals with PTSD, due to the hypersensitized feedback
inhibition, cortisol levels are abnormally lower and CRH levels are higher compared to individuals
without PTSD.
Abbreviation: HPA, hypothalamic-pituitary-adrenal; CRH, corticotrophin-releasing hormone;
ACTH, adrenocorticotropic hormone; PTSD, posttraumatic stress disorder.
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Fig. 2. Participant flow diagram.
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FIG. 3. PCL-C scores measured at baseline, week 4 and week 8.

FIG. 4. Changes in PCL-C scores by subject. Spoke numbers 1-11 correspond to exercise group
subject numbers: n=11. PCL-C scores ranging from 17 to 70 are shown in the 0-70 scale.
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A

B

C

FIG. 5. Changes in PTSD subtypes in exercise group measured at baseline, weeks 4 and 8. A,
reexperiencing; B, avoidance; and C, hyperarousal.
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A

B

FIG. 6. A. Changes in PCL-C scores and serum cortisol (µg/dl) at pre- and postintervention in
exercise group. B. Changes in PCL-C scores and serum cortisol (µg/dl) at pre- and
postintervention in control group.
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FIG. 7. Changes in cortisol levels by subject. Spoke numbers 1-11 correspond to exercise group
subject numbers: n=11.Cortisol levels ranging from 5 to 30 μg/dl are shown in the 0-30 scale.

FIG. 8. Ratios of Cortisol/ACTH and Cortisol/DHEAS at baseline and week 8.
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FIG. 9. Correlations between changes in PCL-C score and cortisol concentration ((µg/dl) at
2
postintervention. R = 0.27. p = 0.437.

FIG. 10. Changes in DHEAS concentration (µg/dl) in participants in exercise group at pre- and
postintervention. DHEAS: dehydroepiandrosterone sulfate.
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CHAPTER IV: SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Summary
Cortisol plays a key role in the pathophysiology of PTSD. Individuals with
chronic PTSD suffer from low basal cortisol levels and research have shown therapeutic
potential of increased cortisol on treating PTSD symptoms. We conducted a prospective
randomized control trial to identify whether mindfulness-based stretching and deep
breathing exercise would increase basal cortisol levels and lead to reduction of PTSD
symptom severity. The followings are our hypotheses and findings:
1. Nurses who are positively screened for PTSD and participate in an 8-week
mindfulness-based stretching and breathing exercises would have greater
changes in cortisol levels compared to the control group.
Our results showed that there was a significant difference in the changes in basal
serum cortisol levels in the exercise group compared to the changes in basal
serum cortisol levels in the control group.
2. Nurses who are positively screened for PTSD and participate in an 8-week
mindfulness-based stretching and breathing exercises would have greater
changes in PTSD symptom severity compared to the control group.
Our data showed that there was a statistically and clinically significant difference
in the changes in PTSD symptom severity in the exercise group measured using
PCL-C instrument compared to the changes in PTSD symptom severity in the
control group.
3. There would be a positive association between exercise-induced reduction in
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PTSD symptom severity and changes in cortisol levels as a result of participating
in an 8-week mindfulness-based stretching and breathing exercises.
There was a significant positive correlation between the participation in the
mindfulness-based stretching and breathing exercise intervention and the PCL-C
scores in the exercise group, however, there was no significant correlation
between the change in cortisol in response to exercise and total PCL-C scores at
postintervention. Future research with larger sample size and cortisol collections
at multiple time points may produce different results.
In summary, we have demonstrated that substantial increases in mind-body
exercise-induced serum cortisol concentration were concurrent with reduced PTSD
symptom severity.

Limitations
This study was conducted with a small number of participants of predominantly
female nurses with PTSD symptoms. Thus the results of the study may not be
generalizable to males and combat veterans.

Conclusions and Applications
Our data demonstrates that short-term mindfulness-based stretching and deep
breathing exercises significantly improves cortisol levels and symptom severity in
individuals with PTSD. Therefore, a program that integrated mind-body exercise may be
an effective nonpharmacologic complementary program for treatment of PTSD.
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Recommendation
Future research should investigate the effect of mind-body exercise-induced
increase in basal cortisol levels on hypothalamic CRH secretion using brain imaging
technology. Further, brain imaging studies may enhance our understanding of the
relationship between the mind-body exercise-induced changes in the dynamics of the
HPA axis and the structural and functional changes in the prefrontal cortex, hippocampus
and amygdala. It would be also interesting to examine the roles of sex-specific genetic
biomarkers and discover individualized gender-specific treatments.
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The University of New Mexico Health Sciences Center
Consent to Participate in Research
The efficacy of mindfulness-based stretching and breathing exercise as a
complementary therapy for posttraumatic stress disorder: A Prospective
Randomized Study
Purpose and General Information
You are being asked to participate in a research study that is being done by Mark R. Burge, MD, who is the
Principal Investigator, and his associates. This research is being done to evaluate the relationship between
exercise-induced reduction in symptoms of stress and exercise-induced changes in cortisol levels. You are
being asked to participate because you are working as a nurse at UNM Hospital and you have met the
study screening criteria. Approximately 33 people will take part in this study at the University of New
Mexico. The CTSC is funding this study.
This form will explain the study to you, including the possible risks as well as the possible benefits of
participating. This is so you can make an informed choice about whether or not to participate in this study.
Please read this Consent Form carefully. Ask the investigators or study staff to explain any words or
information that you do not clearly understand.
It will take approximately 15 minutes to complete this form.

What will happen if I participate?
If you agree to be in this study, you will be asked to read and sign this Consent Form. After you sign the
Consent Form, the following things will happen:
You will be assigned by chance (like a flip of a coin) to either a CONTROL group or EXERCISE group. If
you are assigned to a CONTROL group, don't worry, you will participate in exercise during the second 8week session. The total length of the study is 16 weeks, including an 8-week exercise portion and an 8week non-exercise portion. Prior to beginning the study, you will be asked to fill out a survey and will
have blood drawn. During the 8-week exercise portion of the study, you will be asked to attend a 60minute exercise class twice a week for 8 weeks, you may be asked to fill out a survey twice and will have
blood drawn twice. During the 8-week non-exercise portion of the study, you may be asked to fill out a
survey twice and will have blood drawn twice. The exercise sessions will consist of 10-minute warm-up
with low- to moderate-intensity breathing and conditioning exercises, 40-minute low- to moderateintensity mindfulness-based movement exercise, and 10-minute cool-down. The control condition will
consist of doing the activities you normally do . The instructor of the exercise program will not know the
details of your self-reported stress symptoms as your identity is coded to protect your privacy. However,
this information is available to the principal investigator of the study (PI), and the study coordinator.
You will be asked questions regarding your medical history, current medical conditions including
medications, recent alcohol use including problems associated with alcohol and specific problems related
to illegal drug use or abuse of prescripton drugs.
You will be asked to complete a Physical Activity Readiness Questionnaire (PAR-Q) to be sure you can
safely participate in the exercise program.
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You will be asked to complete a questionnaire that asks about your feelings (such as 'Do you feel
depressed today?') You may refuse to answer any questions at any time. These questionnaires will take
about 30 minutes to complete.
A maximum of eleven mL of blood will be drawn with a needle from a vein in your arm at each blood
draw for laboratory testing to check your cortisol, adrenocorticotropic hormone (ACTH), and
Dehydroepiandrosterone-sulfate (DHEA-S) levels.
The blood collected for this research study will be sent to a central laboratory (TriCore, Albuquerque,
NM). Your name and medical record number will be removed from the sample and labeled with a unique
code number before being shipped.
Participation in this study will take a total of approximately 20 hours over a period of 16 weeks.

What are the possible risks or discomforts of being in this study?
Every effort will be made to protect the information you give us. However, there is a small risk of loss of
confidentiality that may result in stigmatization or hardship.
Other risks and side effects are listed below:
• Blood drawing risks: Drawing blood may cause temporary pain and discomfort from the needle stick,
occasional bruising, sweating, feeling faint or lightheaded and in rare cases infection.
• There are risks of stress, emotional distress, inconvenience and possible loss of privacy and
confidentiality associated with participating in a research study.
• Exercise risks include: musculoskeletal injury. During exercise, you may experience fatigue, nausea,
dizziness, fainting, breathlessness, or dyspnea, or psychological stress. Low- to moderate-intensity exercise
has a very low risk of death or heart attack.

How will my information be kept confidential?
Your name and other identifying information will be maintained in locked files, available only to
authorized members of the research team, for the duration of the study. For any information entered into a
computer, the only identifier will be a unique study identification (ID) number. All written questionaires
completed by you will be coded with a unique identifying number and will never be stored together with
identifiable information to minimize the risk to loss of confidentiality. Any personal identifying
information and any record linking that information to study ID numbers will be destroyed when the study
is completed. Information resulting from this study will be used for research purposes and may be
published; however, you will not be identified by name in any publications.
Information from your participation in this study may be reviewed by federal and state regulatory agencies,
and by the UNM Human Research Review Committee (HRRC) which provides regulatory and ethical
oversight of human research.
To help us further protect the confidentiality of your data, the investigators have obtained a Certificate of
Confidentiality from the National Institutes of Health (NIH). With this Certificate, we cannot be forced
(for example by court subpoena) to disclose research information that may identify you in any Federal,
State, or local civil, criminal, administrative, legislative, or other proceedings. Disclosure of coded data
(your name will not be on it) will be necessary, however, upon request of DHHS (Dept. of Health and
Human Services) or other federal agencies for audit or evaluation purposes.
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You should understand that a Certificate of Confidentiality does not prevent you or a member of your
family from voluntarily releasing information about yourself or your involvement in this research. Note,
however, that if an insurer or employer learns about your participation, and obtains your consent to receive
research information, then the investigator may not use the Certificate to withhold this information. This
means that you and your family must also actively protect your own privacy and the confidentiality of your
data. Finally, you should understand that if the investigators learn about abuse of a child or elderly person
or that you intend to harm yourself or someone else, we will report that information to the proper
authorities.

What are the benefits to being in this study?
There may or may not be direct benefit to you from being in this study. However, your participation may
help find out how treatment for people who suffer from severe stress symptoms can be improved. The
exercise program is noncompetitive, self-paced, low- to moderate-intensity physical stretching, movement
and breathing. Rhythmic movements that are coordinated with breathing may help you experience a sense
of inner calm, improved self-regulation, and reduced feelings of stress. Additionally, the physical exercises
may lead to improved physical fitness including increased muscle tone, flexibility, balance, and
cardiopulmonary capacity.
What other choices do I have if I don’t participate?
Taking part in this study is voluntary so you can choose not to participate.
Will I be paid for taking part in this study?
In return for your time and the inconvenience of participating in this study, you will be paid $20 for the
participation in the first 8-week portion of the study, and additional $30 for the participation in the second
8-week portion of the study. You will receive each stipend approximately (3) weeks after completion of
each 8-week portion of the study.
Can I stop being in the study once I begin?
Yes. You can withdraw from this study at any time without affecting your access to care.
The investigators have the right to end your participation in this study if they determine that you no longer
qualify to take part, if you do not follow study procedures, or if it is in your best interest or the study’s best
interest to stop your participation.

Authorization for Use of Your Protected Health Information (HIPAA)
As part of this study, we will be collecting health information about you. This information is “protected”
because it is identifiable or “linked” to you.
Protected Health Information (PHI)
By signing this Consent Document, you are allowing the investigators and other authorized personnel to
use your protected health information for the purposes of this study. This information may include:
medical history, body mass index, blood cortisol, ACTH, and DHEA-S levels, results of screening
questionaires and information about onging mental health treatment.
In addition to researchers and staff at UNMHSC and other groups listed in this form, there is a chance that
your health information may be shared (re-disclosed) outside of the research study and no longer be
protected by federal privacy laws. Examples of this include disclosures for law enforcement, judicial
proceeding, health oversight activities and public health measures.
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Right to Withdraw Your Authorization
Your authorization for the use of your health information for this study shall not expire unless you cancel
this authorization. Your health information will be used as long as it is needed for this study. However,
you may withdraw your authorization at any time provided you notify the UNM investigators in writing.
To do this, please send a HIPAA Research Withdrawal Form or letter notifying them of your withdrawal
to:
Mark R. Burge, MD
MSC 10-5550
1 University of New Mexico
Albuquerque New Mexico 87131
Please be aware that the research team will not be required to destroy or retrieve any of your health
information that has already been used or shared before your withdrawal is received.

Refusal to Sign
If you choose not to sign this consent form and authorization for the use of your PHI, you will not be
allowed to take part in the research study.
What if I have questions or complaints about this study?
If you have any questions, concerns or complaints at any time about the research study, Mark R. Burge,
MD , or his associates will be glad to answer them at 505-272-0280 during regular business hours. If you
need to contact someone after business hours or on weekends, please call Sang Kim at 505-795-4545. If
you would like to speak with someone other than the research team, you may call the Human Research
Review Committee (HRRC) at (505) 272-1129. The HRRC is a group of people from UNM and the
community who provide independent oversight of safety and ethical issues related to research involving
human subjects.
What are my rights as a research subject?
If you have questions regarding your rights as a research subject, you may call the HRRC at (505) 2721129 or visit the HRRC website at http://hsc.unm.edu/som/research/hrrc/.
Consent and Authorization
You are making a decision whether to participate in this study. Your signature below indicates that you
read the information provided (or the information was read to you). By signing this Consent Form, you are
not waiving any of your legal rights as a research subject.
I have had an opportunity to ask questions and all questions have been answered to my satisfaction. By
signing this Consent Form, I agree to participate in this study and give permission for my health
information to be used or disclosed as described in this Consent Form. A copy of this Consent Form will
be provided to me.
_____________________________
Name of Adult Participant (print)

__________________________/_______
Signature of Adult Participant Date

I have explained the research to the subject and answered all of his/her questions. I believe that he/she
understands the information in this consent form and freely consents to participate.
______________________________
Name of Research Team Member

_________________________/ __________
Signature of Research Team Member/Date
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Demographic Questionnaire
Your Name ________________________

Your Height ____________

How would you classify yourself?
O White(Not Hispanic or Latino)
O Hispanic or Latino (All Races)
O African-American
O American Indian
O Asian
O Pacific Islander
What is the highest level of education you have completed?
O Less than college degree
O College degree
O Graduate school
What is your current marital status?
O Single
O Married
O Divorced
O Widowed
How is your smoking status?
O Current smoker
O Smoked in the past
O Never smoked
How long have you been working as a nurse in the ICU?
O Less than 2 years
O 2-5 years
O 6-10 years
O 11-15 years
O More than 15 years
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Your Weight ____________

Medical History Questionnaire
Demographic Information
Last name					

First name			

Date of birth				

Sex			

Address				

City, State				

Work phone				

Family physician

Middle initial

Home phone
Zip code

Section A
1. When was the last time you had a physical examination?
2. If you are allergic to any medications, foods, or other substances, please name them.
3. If you have been told that you have any chronic or serious illnesses, please list them.
4. Give the following information pertaining to the last 3 times you have been hospitalized.
Note: Women, do not list normal pregnancies.
Hospitalization
1

Hospitalization
2

Hospitalization
3

Reason for
hospitalization
Month and year
of hospitalization
Hospital
City and state
Section B
During the past 12 months

1. Has a physician prescribed any form of medication for you?
2. Has your weight fluctuated more than a few pounds?
3. Did you attempt to bring about this weight change through diet or exercise?
4. Have you experienced any faintness, light-headedness, or blackouts?
5. Have you occasionally had trouble sleeping?		
6. Have you experienced any blurred vision?		
7. Have you had any severe headaches?		
8. Have you experienced chronic morning cough?
9. Have you experienced any temporary change in your speech pattern, such as
slurring or loss of speech?				
10. Have you felt unusually nervous or anxious for no apparent reason?
11. Have you experienced unusual heartbeats such as skipped beats or palpitations?
12. Have you experienced periods in which your heart felt as though it were racing
for no apparent reason?				

❐ Yes
❐ Yes
❐ Yes
❐ Yes
❐ Yes
❐ Yes
❐ Yes
❐ Yes

❐ No
❐ No
❐ No
❐ No
❐ No
❐ No
❐ No
❐ No

❐ Yes ❐ No
❐ Yes ❐ No
❐ Yes ❐ No
❐ Yes

❐ No

APPENDIX A.2
From Advanced Fitness Assessment and Exercise Prescription, Sixth Edition, by Vivian H. Heyward, 2010, Champaign, IL: Human Kinetics.
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At present

1. Do you experience shortness or loss of breath while walking with others
your own age?					
2. Do you experience sudden tingling, numbness, or loss of feeling in your arms,
hands, legs, feet, or face?				
3. Have you ever noticed that your hands or feet sometimes feel cooler than other
parts of your body?					
4. Do you experience swelling of your feet and ankles?
5. Do you get pains or cramps in your legs?		
6. Do you experience any pain or discomfort in your chest?
7. Do you experience any pressure or heaviness in your chest?
8. Have you ever been told that your blood pressure was abnormal?
9. Have you ever been told that your serum cholesterol or triglyceride level
was high?						
10. Do you have diabetes?				
		If yes, how is it controlled?
		❐ Dietary means
❐ Insulin injection
		❐ Oral medication ❐ Uncontrolled
11. How often would you characterize your stress level as being high?
		❐ Occasionally
❐ Frequently ❐ Constantly
12. Have you ever been told that you have any of the following illnesses?

❐ Yes

❐ No

❐ Yes

❐ No

❐ Yes
❐ Yes
❐ Yes
❐ Yes
❐ Yes
❐ Yes

❐ No
❐ No
❐ No
❐ No
❐ No
❐ No

❐ Yes ❐ No
❐ Yes ❐ No

❐ Yes

❐ No

		❐ Myocardial infarction
❐ Arteriosclerosis
❐ Heart disease ❐ Thyroid disease
		❐ Coronary thrombosis
❐ Rheumatic heart ❐ Heart attack
❐ Heart valve disease
		❐ Coronary occlusion
❐ Heart failure
❐ Heart murmer
		❐ Heart block
❐ Aneurysm
❐ Angina
13. Have you ever had any of the following medical procedures?
❐ Yes ❐ No
		❐ Heart surgery
		❐ Cardiac catheterization
		❐ Coronary angioplasty

❐ Pacemaker implant
❐ Defibrilator
❐ Heart transplantation

Section C

Has any member of your immediate family been treated for or suspected to have had any of these conditions? Please identify their relationship to you (father, mother, sister, brother, etc.).
A. Diabetes
B. Heart disease
C. Stroke
D. High blood pressure
APPENDIX A.2
From Advanced Fitness Assessment and Exercise Prescription, Sixth Edition, by Vivian H. Heyward, 2010, Champaign, IL: Human Kinetics.
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PAR-Q & YOU

Physical Activity Readiness
Questionnaire - PAR-Q
(revised 2002)

(A Questionnaire for People Aged 15 to 69)
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being more active is very safe for most
people. However, some people should check with their doctor before they start becoming much more physically active.
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box below. If you are between the
ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start. If you are over 69 years of age, and you are not used to being
very active, check with your doctor.
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one honestly: check YES or NO.
YES

NO

If
you
answered

1.

Has your doctor ever said that you have a heart condition and that you should only do physical activity
recommended by a doctor?

2.

Do you feel pain in your chest when you do physical activity?

3.

In the past month, have you had chest pain when you were not doing physical activity?

4.

Do you lose your balance because of dizziness or do you ever lose consciousness?

5.

Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a
change in your physical activity?

6.

Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition?

7.

Do you know of any other reason why you should not do physical activity?

YES to one or more questions
Talk with your doctor by phone or in person BEFORE you start becoming much more physically active or BEFORE you have a fitness appraisal. Tell
your doctor about the PAR-Q and which questions you answered YES.
• You may be able to do any activity you want — as long as you start slowly and build up gradually. Or, you may need to restrict your activities to
those which are safe for you. Talk with your doctor about the kinds of activities you wish to participate in and follow his/her advice.
• Find out which community programs are safe and helpful for you.

➔

NO to all questions
If you answered NO honestly to all PAR-Q questions, you can be reasonably sure that you can:
• start becoming much more physically active – begin slowly and build up gradually. This is the
safest and easiest way to go.
• take part in a fitness appraisal – this is an excellent way to determine your basic fitness so
that you can plan the best way for you to live actively. It is also highly recommended that you
have your blood pressure evaluated. If your reading is over 144/94, talk with your doctor
before you start becoming much more physically active.

DELAY BECOMING MUCH MORE ACTIVE:
• if you are not feeling well because of a temporary illness such as
a cold or a fever – wait until you feel better; or
• if you are or may be pregnant – talk to your doctor before you
start becoming more active.

PLEASE NOTE: If your health changes so that you then answer YES to
any of the above questions, tell your fitness or health professional.
Ask whether you should change your physical activity plan.

Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability for persons who undertake physical activity, and if in doubt after completing
this questionnaire, consult your doctor prior to physical activity.

No changes permitted. You are encouraged to photocopy the PAR-Q but only if you use the entire form.
NOTE: If the PAR-Q is being given to a person before he or she participates in a physical activity program or a fitness appraisal, this section may be used for legal or administrative purposes.

"I have read, understood and completed this questionnaire. Any questions I had were answered to my full satisfaction."
NAME ________________________________________________________________________
SIGNATURE _______________________________________________________________________________

DATE______________________________________________________

SIGNATURE OF PARENT _______________________________________________________________________
or GUARDIAN (for participants under the age of majority)

WITNESS ___________________________________________________

Note: This physical activity clearance is valid for a maximum of 12 months from the date it is completed and
becomes invalid if your condition changes so that you would answer YES to any of the seven questions.
© Canadian Society for Exercise Physiology

Supported by:
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continued on other side...

PCL-C
Your Name: ________________________________
Instructions: Below is a list of problems and complaints that people sometimes have in response
to stressful life experiences. Please read each one carefully, put an “X” in the box to indicate
how much you have been bothered by that problem in the last month.

NO.

Response

1.

Repeated, disturbing memories, thoughts, or
images of a stressful experience from the
past?

2.

Repeated, disturbing dreams of a stressful
experience from the past?

3.

Suddenly acting or feeling as if a stressful
experience were happening again (as if you
were reliving it)?

4.

Feeling very upset when something reminded
you of a stressful experience from the past?

5.

Having physical reactions (e.g., heart
pounding, trouble breathing, or sweating)
when something reminded you of a stressful
experience from the past?

6.

Avoid thinking about or talking about a
stressful experience from the past or avoid
having feelings related to it?

7.

Avoid activities or situations because they
remind you of a stressful experience from the
past?

8.

Trouble remembering important parts of a
stressful experience from the past?

9.

Loss of interest in things that you used to
enjoy?

10.
11.

Feeling distant or cut off from other people?

12.

Feeling as if your future will somehow be cut
short?

13.
14.
15.
16.
17.

Trouble falling or staying asleep?

Not at all
(1)

Feeling emotionally numb or being unable to
have loving feelings for those close to you?

Feeling irritable or having angry outbursts?
Having difficulty concentrating?
Being “super alert” or watchful on guard?
Feeling jumpy or easily startled?

PCL-C for DSM-IV (11/1/94) Weathers, Litz, Huska, & Keane
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A little bit
(2)

Moderately
(3)

Quite a bit
(4)

Extremely
(5)

CASAA Research Division*
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Please circle the answer that is correct for you.
1. How often do you have a drink containing alcohol?
NEVER

MONTHLY OR
LESS

TWO TO FOUR
TIMES A MONTH

TWO TO THREE
TIMES A WEEK

FOUR OR MORE
TIMES A WEEK

NOTE: For answering these questions, one Adrink@ is equal to 10 ounces of beer, or 4 ounces of
wine, or 1 ounce of liquor
2. How many drinks containing alcohol do you have on a typical day when you are drinking?
1 OR 2

2 OR 4

5 OR 6

7 TO 9

10 OR MORE

WEEKLY

DAILY OR
ALMOST DAILY

3. How often do you have six or more drinks on one occasion?
NEVER

LESS THAN
MONTHLY

MONTHLY

4. How often during the last year have you found that you were not able to stop drinking once you
had started?
NEVER

LESS THAN
MONTHLY

MONTHLY

WEEKLY

DAILY OR
ALMOST DAILY

5. How often during the last year have you failed to do what was normally expected from you
because of drinking?
NEVER

LESS THAN
MONTHLY

MONTHLY

WEEKLY

DAILY OR
ALMOST DAILY

6. How often during the last year have you needed a first drink in the morning to get yourself
going after a heavy drinking session?
NEVER

LESS THAN
MONTHLY

MONTHLY

WEEKLY

DAILY OR
ALMOST DAILY

7. How often during the last year have you had a feeling of guilt or remorse after drinking?
NEVER

LESS THAN
MONTHLY

MONTHLY

WEEKLY

DAILY OR
ALMOST DAILY

8. How often during the last year have you been unable to remember what happened the night
before because you had been drinking?
NEVER

LESS THAN
MONTHLY

MONTHLY

WEEKLY

DAILY OR
ALMOST DAILY

9. Have you or someone else been injured as a result of your drinking?
NEVER

YES, BUT NOT IN
THE LAST YEAR

YES, DURING
THE LAST YEAR

10. Has a relative or friend, or a doctor or other health worker been concerned about your
drinking or suggested you cut down?
NEVER

YES, BUT NOT IN

100

YES, DURING

Id. nr.

DUDIT

Drug Use Disorders Identification Test

Here are a few questions about drugs. Please answer as correctly and honestly
as possible by indicating which answer is right for you.
Man

Woman

1. How often do you use drugs
other than alcohol?
(See list of drugs on back side.)

2. Do you use more than one
type of drug on the same
occasion?

Age

Never

Once a month or
less often

2-4 times
a month

2-3 times
a week

4 times a week
or more often

Never

Once a month or
less often

2-4 times
a month

2-3 times
a week

4 times a week
or more often

5-6

7 or more

3. How many times do you take drugs

0

1-2

3-4

on a typical day when you use drugs?
Never

Less often than
once a month

Every
month

Every
week

Daily or almost
every day

Never

Less often than
once a month

Every
month

Every
week

Daily or almost
every day

Never

Less often than
once a month

Every
month

Every
week

Daily or almost
every day

7. How often over the past year have you Never
taken drugs and then neglected to do
something you should have done?

Less often than
once a month

Every
month

Every
week

Daily or almost
every day

8. How often over the past year have

Never

Less often than
once a month

Every
month

Every
week

Daily or almost
every day

Never

Less often than
once a month

Every
month

Every
week

Daily or almost
every day

4. How often are you influenced heavily
by drugs?

5. Over the past year, have you felt
that your longing for drugs was so
strong that you could not resist it?

© 2002 Anne H. Berman, Hans Bergman, Tom Palmstierna & Frans Schlyter Europé English version 1
Karollinska Institutet, Stockholm, Sweden. Correspondence: + 46 8 517 74869, anne.h.berman@chess.su.se

6. Has it happened, over the past year,
that you have not been able to stop
taking drugs once you started?

you needed to take a drug the morning
after heavy drug use the day before?

9. How often over the past year have
you had guilt feelings or a bad
conscience because you used drugs?

10. Have you or anyone else been hurt

No

Yes, but not over the past year

Yes, over the past year

No

Yes, but not over the past year

Yes, over the past year

(mentally or physically) because
you used drugs?

11. Has a relative or a friend, a doctor
or a nurse, or anyone else, been
worried about your drug use or said to
you that you should stop using drugs?
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Turn the page to see the list of drugs

LIST OF DRUGS
(Note! Not alcohol!)

Cannabis

Amphetamines

Marijuana Methamphetamine
Phenmetraline
Hash
Khat
Hash oil
Betel nut
Ritaline
(Methylphenidate)

Cocaine Opiates

Hallucinogens

Solvents/inhalants GHB and others

Crack
Smoked heroin
Freebase Heroin
Coca
Opium
leaves

Ecstasy
LSD (Lisergic acid)
Mescaline
Peyote
PCP, angel dust
(Phencyclidine)
Psilocybin
DMT
(Dimethyltryptamine)

Thinner
Trichlorethylene
Gasoline/petrol
Gas
Solution
Glue

GHB
Anabolic steroids
Laughing gas
(Halothane)
Amyl nitrate
(Poppers)
Anticholinergic
compounds

PILLS – MEDICINES

© 2002 Anne H. Berman, Hans Bergman, Tom Palmstierna & Frans Schlyter Europé English version 1
Karollinska Institutet, Stockholm, Sweden. Correspondence: + 46 8 517 74869, anne.h.berman@chess.su.se

Pills count as drugs when you take
•
•
•
•

more of them or take them more often than the doctor has prescribed for you
pills because you want to have fun, feel good, get ”high”, or wonder what sort of effect they
have on you
pills that you have received from a relative or a friend
pills that you have bought on the ”black market” or stolen

SLEEPING PILLS/SEDATIVES
Alprazolam
Amobarbital
Apodorm
Apozepam
Aprobarbital
Butabarbital
Butalbital
Chloral hydrate
Diazepam
Dormicum
Ethcholorvynol
Fenemal
Flunitrazepam
Fluscand

Glutethimide
Halcion
Heminevrin
Iktorivil
Imovane
Mephobarbital
Meprobamate
Methaqualone
Methohexital
Mogadon
Nitrazepam
Oxascand
Pentobarbital
Phenobarbital

Rohypnol
Secobarbital
Sobril
Sonata
Stesolid
Stilnoct
Talbutal
Temesta
Thiamyal
Thiopental
Triazolam
Xanor
Zopiklon

PAINKILLERS
Actiq
Coccilana-Etyfin
Citodon
Citodon forte
Dexodon
Depolan
Dexofen
Dilaudid
Distalgesic
Dolcontin
Doleron
Dolotard
Doloxene

Durogesic
Fentanyl
Ketodur
Ketogan
Kodein
Maxidon
Metadon
Morfin
Nobligan
Norflex
Norgesic
Opidol
OxyContin

OxyNorm
Panocod
Panocod forte
Paraflex comp
Somadril
Spasmofen
Subutex
Temgesic
Tiparol
Tradolan
Tramadul
Treo comp

Pills do NOT count as drugs if they have been prescribed by a doctor and
you take them in the prescribed dosage.
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Stress Study
Referral Handout
In the questionnaire that you completed as part of this study, you indicated that you have higher
than average levels of stress. Over time, elevated stress levels may negatively impact your daily
life. Participation in this study may help you manage your stress levels, however, you may also
wish to seek additional counseling or treatment on your own by consulting your family physician
or a health care provider of your choice. For your reference, the following is a list of some of the
resources in the community that provide mental health counseling and treatment.
Outcomes Inc.
Employee Assistance Program
1503 University Blvd. NE
Albuquerque, NM 87102-1708
(505) 243-2551

Presbyterian Healthcare Services
Presbyterian Behavioral Health
1325 Wyoming Blvd NE
Albuquerque, NM 87112-5046
(505) 291-5300

The University of New Mexico
School of Medicine
Family Practice/Psychiatry Center
2400 Tucker NE, MSC09 5040
1 University of New Mexico
Albuquerque, NM 87131-0001
(505) 272-2165

Lovelace Medical Center
Lovelace Behavioral Health
601 Dr. Martin Luther King Jr. Ave. NE
Albuquerque, NM 87102
(505)727-8000

Susan P. Kaspi, Ph.D.
Behavior Therapy Associates
9426 Indian School Rd NE, Suite 1.
(505)345-6100

Christus St. Vincent
Behavioral Health Services
2052 Galisteo Street
Santa Fe, NM 87505
(505) 913-4350

Study Contact Information:
Sara Newman, Study Coordinator
StressStudy@salud.unm.edu
(505) 272-0280
Sang Kim, Researcher
Dept. of Health, Exercise & Sports Sciences
sangkim@unm.edu
(505) 795-4545
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Emergency Risk Evaluation Protocol
Should a participant give any indication of being suicidal, homicidal, or psychotic during an
interaction, the following steps are to be taken:
Calmly tell the participant to wait in the assessment room. If someone is available to sit
with them, this is ideal. Do not tell the participant that you are calling a psychologist to
perform a risk evaluation.
Call the study PI Mark Burge, MD at 951-1465.
The person who conducts the risk evaluation should report the details of the event to the
PI. The completed note (see attached) should be kept in the study records.
If a participant is determined to be actively suicidal, homicidal, or psychotic, then campus
police should be called to escort them to the UNM psychiatric emergency.
Campus Police may be reached at 277-2241 from a cell phone or
911 from any UNM landline.
If the participant is not at acute risk, they are to be given a list of community resources
where they can seek mental health counseling.
Actively suicidal, homicidal, or psychotic participants are to be excluded from the study in
order to ensure the safety of participants and staff.
Should the participant require an escort to emergency care, the incident will be reported to
PI Mark Burge, MD and to the HRRC as an adverse event.
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Document Note
Risk Evaluation Date:
Study and HRRC#:
Reason for evaluation:
MSE:
Appearance: WNL Grooming and hygiene ok
Behavior: Friendly, cooperative, and engaged
Speech: WNL, RRR, Clear and coherent
Mood and Affect: Pt describes mood as _____________ BDI = _____, Affect full and appropriate
Thought Process: WNL, linear, logical, goal directed,
Thought Content: WNL, no AH/VH, no delusions or obsessions
Insight and Judgment: WNL
Suicide Risk:
Primary Risk factors: Axis I d/o, SUD, Axis II d/o, Fam hx of suicide, Past hx of suicide attempt, Recent d/c
from Ψ hosp, Developmental trauma
Demographic Risk: white or native American male over 40, divorced, widowed, or separated
Environmental Risk: Access to gun, firearm; exposure to model for suicide
Protective Factors: strong personal support system, strong therapeutic support system, strong faith or belief
system opposing suicide as an option
Acute risk factors: Acute stressors/losses (financial, relationship, employment, physical health, pain, etc),
affective system factors (rage, fear, anxiety, shame, loneliness, burdensomeness, depression, pessimism, etc.),
Impaired problem solving (dichotomous thinking rigidity)
Suicidality: hopelessness only, passive wish to die only, thought of ending life – with plan, - with intent, - with
means, - with rehearsal behavior, - that are persistent, - that are accompanied by command hallucinations
Suicide Risk: Initial Plan: Discussed with patient and
Patient education: 1) confidentiality discussed with pt, 2) cognitive/physical/cultural barriers, 3)
motivation/ability/readiness to learn, 4) other
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RESEARCH
OPPORTUNITY
Be part of an important research study on the effects of stress in nurses.
• Are you a nurse at UNM?
• Is job-related stress impacting your professional fulfillment or personal wellbeing?
• Do you want to reduce your stress levels without medication?
• If you answered YES to these questions, you may be eligible to participate in a
research study being conducted at UNM.
The purpose of this research study is to investigate the therapeutic effectiveness of
low- to moderate-intensity mind-body exercise on stress.
Benefits include participation in a free 8-week mind-body group exercise class (1
hour, twice weekly). Participants will receive two small stipends for successful
completion of the study. No medications will be given.
This study is being conducted at UNM Clinical and Translational Science Center in
partnership with the UNM Health, Exercise and Sports Sciences Department.
Please call Sara Newman at (505) 272-0280
or
email StressStudy@salud.unm.edu for more information.
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Your Name:

Home Exercise Log
Date

Total Minutes

Type of Exercise

(MM/DD)

(30, 45, 60, 75, etc)

(Example: walking, jogging, swimming, weight training, fitness class etc.)
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Examples of mind-body stretching and breathing exercises.
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